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Introduction: Non-specific persistent low back pain is one of the most prevalent 
musculoskeletal conditions in modern society. A growing body of evidence shows graded 
exposure therapy is the most preferable treatment to target pain-related fear of movement. 
However, graded exposure therapy has some limitations, e.g. low patient preference and high 
drop-out rates. Therefore, the emerging nature of Virtual Reality (VR) provides an interesting 
medium to investigate whether pain and pain-related fear can be targeted through graded 
exposure using immersive virtual environments.  
Method: In a sequential replicated and randomized single-subject experimental design with 
multiple measurements, 10 patients with non-specific persistent low back pain had a 35-day 
intervention with 6 to 9 VR training sessions. Primary outcome measures (measured daily) were 
pain intensity, pain-related fear of movement, pain catastrophization and pain anxiety 
symptoms, while secondary outcome measures (measured pre- and post-intervention) were 
related to disability and activities of daily life.  
Results: VR training resulted in a statistically significant reduction of pain intensity, pain-
related fear of movement, pain catastrophizing, and pain anxiety. Clinically relevant 
improvements were observed for disability.  
Conclusion/Future implications: There is a need to reduce the costs and suffering caused by 
persistent low back pain. VR may provide opportunities to exercise in specifically tailored 
virtual environments, with the goal of achieving meaningful and valued life-activities in an 
engaging fashion. However, the technology is only in its infancy, and thus, opportunities and 
challenges with implementation must be further investigated. Finally, given the nature of the 
present study design, the results cannot be generalized to a larger population, and therefore, 
further research involving rigorous trial designs (randomised controlled trial) is also warranted. 
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Introduksjon: Langvarige korsryggsmerter er blant de mest prevalente muskel- og 
skjelettplagene i det moderne samfunnet. Stadig mer forskning viser at smerte-relatert frykt for 
bevegelse kan opprettholde funksjonstap hos mange ryggpasienter, og at gradvis 
eksponeringsterapi er blant de mest effektive behandlingsmetodene. Men gradvis 
eksponeringsterapi har begrensninger som bl.a. lav pasient-preferanse og høy drop-out rate. På 
bakgrunn av den nylige teknologiske utviklingen av Virtual Reality (VR), åpnes det utforskning 
av effekten av gradvis eksponeringstrening for ryggpasienter i ulike virtuelle miljø. 
Metode: I et sekvensielt replisert, randomisert singel-subjekt eksperimentelt design med 
gjentatte målinger, gjennomgikk 10 ryggpasienter en 35-dagers intervensjon som bestod av et 
minimum av 6 VR-treninger og maksimum av 9 VR-treninger. Primære utfallsmål bestod av 
smerteintensitet, smerte-relatert frykt, katastrofetanker og angst for smerte, mens sekundære 
utfallsmål målte endringer i funksjonsnivå og aktiviteter i dagliglivet.  
Resultater: Studien viste at VR-trening hadde en statistisk signifikant effekt på 
smerteintensitet, smerte-relatert frykt, katastrofetanker og angst for smerte. Klinisk relevante 
endringer ble observert for endringer i funksjonsnivå.  
Konklusjon/Fremtidige implikasjoner: Det er et stort behov for å redusere kostnader og 
lidelse forbundet med ryggsmerter. Tilpasset trening i ulike virtuelle miljø i VR bør undersøkes 
nærmere ettersom det fremstår som et motiverende og kostnadseffektivt hjelpemiddel for bruk 
i fysioterapipraksis. Men teknologien er fortsatt i utviklingsstadiet, og det trengs fortsatt 
oversikt over muligheter og utfordringer ved implementering. Forskerne i denne studien 
anerkjenner at resultatene av studien ikke kan generaliseres til en større populasjon grunnet 
studiedesign, og at det er behov for studier randomiserte kontrollerte studier på dette feltet. 
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1.0. Theoretical Background 
1.1. The Global Burden of Low Back Pain 
Low back pain (LBP) is a very common diagnosis, and the leading cause of disability world-
wide (Buchbinder et al, 2018). Globally, the number of years lived with disability caused by 
LBP increased by 54% between 1990 and 2015 (Buchbinder et al, 2018). The lifetime 
prevalence is reported to be as high as 84% (Airaksinen et al, 2006), and although most episodes 
of LBP improve substantially within six weeks, 67% of people with LBP still report pain at 
three months. Further, approximately 33% of people are reported to have a recurrent episode of 
LBP within one year (da Silva et al, 2017). Three to 10% of people with LBP go on to develop 
persistent LBP (Koes et al, 2010), and a study from 2015 estimated that at any given time, 540 
million people are suffering from LBP (Buchbinder et al, 2015).  
LBP is also the leading persistent health problem that forces people out of the workplace and 
forces older workers to retire prematurely – more than heart disease, diabetes, hypertension, 
neoplasm, respiratory disease, and asthma combined (Schofield et al, 2008). People with 
physically demanding jobs, physical and mental co-morbidities, smokers and obese individuals 
are at greatest risk of reporting LBP (Hartvigsen et al, 2018). For the individual, LBP can have 
profound economic consequences as they accumulate less wealth than those without the 
problem, and the negative effect on wealth increases with the presence of comorbidities 
(Schofield et al, 2012; 2015). In 2003, almost 43.000 Norwegian citizens received disability 
benefits due to LBP, and every year, approximately 4000-5000 Norwegian citizens start 
receiving disability pension because of LBP (Rikstrygdeverket, 2004). LBP is estimated to cost 
Norway 13-15 Billion Norwegian Kroners (NOK) every year, and most costs are related to sick 
leave, disability fees, loss of production and utilization of health care services (Brage & Lærum, 
1999). Studies from Hashemi et al. (1998) and Williams et al. (1998) suggest that replacement 
wages accounts for 80-90% of the total costs related to LBP, and consistently, only a small 
percentage of LBP cases account for these costs. 
Most LBP is characterized as non-specific, meaning that for most people (an estimated 90%) 
the pain cannot be attributed to a specific cause (Koes et al, 2006). Deyo & Weinstein (2001) 
estimated that of patients with LBP in primary care, in only 10% could LBP be attributed to a 
specific cause. In their study, of those patients with a specific cause for their LBP, 
approximately 4% had a compression fracture, 3% had spinal stenosis, 2% had visceral disease, 
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0,7% a tumour or metastasis, and 0,01% an infection. A vast majority of LBP patients have 
traditionally been screened with x-ray or Magnetic Resonance Imaging (MRI), as the “gold 
standard” to discover disc- or spinal pathology. While imaging can play an important role in 
revealing “red flags” in a small number of LBP patients, recent evidence suggests that both 
symptomatic and asymptomatic adults have a high prevalence of common degenerative features 
in the imaging reports (Brinjikji et al, 2014), limiting the diagnostic value of these findings. 
Pressingly, the communication of perceived abnormal spinal imaging findings (i.e. bulging 
discs or disc degeneration) has been suggested to increase patients’ fear of re-injury and reduce 
the likelihood of a good outcome (Roland & Van Tulder, 1998). Moreover, adverse effects of 
early imaging of the lumbar spine have also been reported, including worse disability and 
increased medical and surgical costs, unrelated to LBP severity (Graves et al, 2012; Webster & 
Cifuentes, 2010). In the recently published Lancet series viewpoint by Buchbinder et al. (2018), 
one of the key messages is to promote “positive health”, i.e. “the ability to adapt and to self-
manage, and address widespread misconceptions in the population an among health 
professionals about the causes, prognosis, and effectiveness of different treatments” 
(Buchbinder et al, 2018, p. 2384). As persistent LBP continues to burden our society, it is 
crucial that stakeholders, researchers and clinicians understand the multidimensional aspects of 
non-specific LBP, and that looking to the future, we focus on health-promoting factors such as 
lifestyle, behaviours, thoughts and beliefs related to LBP, rather than continuing to look for a 
solely peripheral cause for a multidimensional health problem. 
 
1.2.Multidimensional framework for non-specific Low Back Pain 
The lack of diagnostic value in screening for biomedical causes of non-specific LBP has led to 
a conceptual shift in underlying theories of LBP and in its treatment. Contemporary scientific 
theories propose that non-specific LBP can be considered a neuro-biological and behavioural 
response to an individual’s actual and/or perceived threat to their body, lifestyle, social 
circumstances and/or disruption to their homeostasis (Marchand et al, 2005; Moseley & Butler, 
2015; Wand et al, 2011). As described by O’Sullivan et al. (2012; 2016; 2018a), our biological 
system constantly interacts and is influenced by physical, psychological, social, and lifestyle 
factors as well as by other comorbidities and non-modifiable factors (i.e. genetics, gender, life 
stage). Recent findings have therefore shifted both researcher’s and clinician’s awareness and 
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understanding of LBP towards modifiable and non-modifiable factors in non-specific persistent 








Figure 1: Modifiable and non-modifiable factors in an individual’s LBP experience (O’Sullivan et al, 
2018a) 
As depicted in Figure 1, both co-morbid health factors and neuro-immune-endocrine factors, 
and an array of modifiable and non-modifiable factors contribute to a person’s LBP experience. 
Therefore, non-specific LBP must be considered as a multidimensional disorder (O’Sullivan, 
2016, 2018a), without any “quick fixes” or “magic bullets”. Due to the complexity and 
heterogeneity of the condition, the challenge of getting the patient, the treatment, and the timing 
“right”, is a formidable one.  
 
1.3.Current consensus on Low Back Pain treatment 
There is almost an endless list of treatment options currently available to patients with LBP, 
but according to Foster (2011), “no conservative treatment has large, significant and consistent 
benefits for patients with NSCLBP”. Recommendations from a recent systematic review in the 
Lancet state that “a bio-psycho-social framework to guide management with initial non-
pharmacological treatment, including education that supports self-management and resumption 
of normal activities and exercise, and psychological programmes for those with persistent 
symptoms” is needed (Foster et al, 2018, p. 2368). Systematic reviews of passive therapeutic 
interventions (so-called “hands-on” treatments) such as muscle energy techniques (Franke et 
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al, 2015), chiropractic treatment (Walker et al, 2010), spinal manipulation (Assendelft et al, 
2013), massage (Furlan et al, 2015), ultrasound (Ebadi et al, 2014) and traction (Wegner et al, 
2013) show small or non-significant clinical effects. Other systematic reviews investigating 
active treatments (so-called “hands-off” treatments) such as Pilates (Yamato et al, 2015), 
behavioural therapy (Henschke et al, 2010), back schools (Poquet et al, 2016), motor control 
exercises (Saragiotto et al, 2016), stabilization exercises (Smith et al, 2014), patient education 
(Louw et al 2011; 2013; Moseley & Butler, 2003; 2017) and multidisciplinary rehabilitation 
(Kamper et al, 2015) show that active therapies have an overall better treatment effect than 
passive therapies. However, active therapies are also largely consistent in terms of clinical 
effect (i.e. one active treatment is not better than another).  
The overall, current consensus is that multidimensional rehabilitation with the use of 
behavioural therapy and supervised exercise should be first-line treatment (Chou et al, 2007; 
Daffada et al, 2015; Kamper et al, 2015; Koes et al, 2010; Savigny et al, 2009; Turk, 1996). 
The recent development of Cognitive Functional Therapy (CFT) may be an example of this 
suggested approach (O’Sullivan et al, 2015; Fersum et al, 2013). CFT is defined as an 
integrated, flexible behavioural approach for people with disabling, non-specific LBP, based 
on a multidimensional “clinical reasoning framework” to identify and treat key modifiable 
factors from the clinical history and assessment (O’Sullivan et al, 2018). Additionally, 
behavioural-educational approaches like Explain Pain (Moseley & Butler, 2003; 2017) and 
Therapeutic Neuroscience Education (Louw et al, 2013) have gained considerable attention 
amongst health-care professionals over the past 10-15 years, due to their usefulness in patient 
education and behavioural change. The unifying aspect of Explain Pain and Therapeutic 
Neuroscience Education is to provide a functional pain literacy and help make sense of a 
patients’ subjective pain experience, based on explanations of the key (neuro)-biological (and 
neurophysiological) concepts that underpin pain (Louw et al, 2013; Moseley & Butler, 2015). 
Furthermore, a new line of research from experimental clinical neuroscience has investigated 
the role of the brain in persistent pain, and suggests that re-organisation in different areas and 
networks in the brain may contribute to persistent pain (Flor et al, 1997; Moseley & Flor, 2012). 
Experimental studies have shown that there is evidence for perceptual dysfunctions in people 
with LBP, i.e. alterations in perceived shape of the back (Moseley, 2008a); reduced tactile 
acuity at the back (Catley et al, 2014, Moseley, 2008b; Wand et al, 2010; 2011a); impaired 
motor imagery of the back (Bray & Moseley, 2011); and impaired trunk voluntary motor control 
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(Luomajoki & Moseley, 2011). Further, studies have shown that therapies targeting these 
perceptual dysfunctions improve symptoms in LBP (Kählin, 2016; Wand et al, 2011b; 2015; 
Louw et al, 2015; Daffada et al, 2015). Further, recent work by Stanton et al. (2017) suggests 
that perceptual dysfunction in people with LBP may also extend to feelings of stiffness in the 
back, which is one of the most common complaints for LBP patients alongside pain. Further 
research in this field may help provide researchers and clinicians to develop increased 
knowledge about pain perception, which can be then translated to the clinic for patients 
struggling with LBP. However, robust scientific trials (i.e. randomised controlled trials) are 
needed.  
The current challenges facing modern physiotherapists appear to be having the skills to: 1) to 
navigate in the “landscape” of modifiable factors in LBP, 2) to become “strategists” that can 
educate and provide short- and long-term health promoting strategies for the patient, and 3) 
promote self-efficacy and resilience (focus on salutogenesis – focus on health – versus 
pathogenesis) to improve clinical outcomes. To achieve these goals, new technology may 
provide us with helpful tools to facilitate learning and behavioural change (see further 
discussion of these topics in Subsection 1.4., 1.5. and 1.6). 
 
1.4. The Fear-Avoidance Model  
One leading cognitive-behavioural theory underpinning why certain individuals develop 
persistent pain and disability following acute back injury, derives from the “Fear-Avoidance 
(FA) Model of Musculoskeletal Pain” (Figure 2) (Vlaeyen, 2000; Vlaeyen & Linton, 2012).  
 
Figure 2: FA model (Vlaeyen, 2000) 
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In brief, the FA model postulates that fear of re-injury and catastrophization play an important 
role in shaping maladaptive behaviours, such as avoidance and disuse, which may then 
predispose to chronicity. Kori et al. (1990) defined “kinesiophobia” as an excessive, irrational 
and debilitating fear of movement and activity stemming from a feeling of being more fragile 
or vulnerable to experiencing a painful injury or re-injury. A variety of conceptual definitions 
have been suggested through the years, e.g., “kinesiophobia”, “fear-avoidance beliefs”, “fear 
of movement”, while “pain-related fear of movement” seem to be the most currently valid 
definition. In a critical review, Lundberg et al. (2011) argued that the different definitions of 
pain-related fear of movement are merely constructs (i.e., rather than a disorder or pathological 
state itself), which is important for researchers and clinicians to be aware of as it creates 
challenges with construct validity and when attempting to create reliable assessment tools 
related to the construct. Therefore, pain- and behavioural researchers are currently attempting 
to unravel the intertwined relationship between the development of pain-related fear of 
movement and development of persistent pain.  
A challenge in LBP is that pain is often unpredictable, making it difficult limit avoidance 
behaviour to only one activity. Further, the experience of unpredictable pain fluctuations can 
trigger anticipatory pain-related fear of movement (Meulders & Bennett, 2018), and it has been 
shown that associative learning processes and neuroplasticity plays an important role for the 
acquisition of pain-related fear of movement (Meulders, Vansteenwegen & Vlaeyen, 2011). 
Moreover, a patient may implicitly generalise the threat value of one movement to another, 
negating the need to learn a new association between that new movement and fear (Meulders 
et al, 2017). For example, pain while lifting a heavy box may result in fear of lifting a box (and 
avoidance of this activity), however, over time this may lead to generalization of fear and thus 
avoidance of all lumbar spine flexion movements regardless of the situation (e.g., bending 
forward in a chair). A recent study found that people with LBP showed implicit associations 
between perceived danger and images of a “rounded” or “neutral” lumbar spine position in 
lifting (Caneiro et al, 2017). The notion of implicit association in persistent pain may warrant 
further investigation, because there is some evidence that assimilation of perceptual danger-
relevant cues (that we are unaware of) can influence movement and behaviour (Moseley & 
Vlaeyen, 2015). Pressingly, persistently avoiding valued activities of daily life (ADL) 
negatively affects physical performance, mood and sense of self (Meulder & Bennett, 2018), 
and is therefore an important aspect to target (if present). One promising approach is to address 
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pain-related fear of movement with graded exposure therapy, which will be further discussed 
in the next subsection. 
 
1.5. Graded exposure for pain-related fear of movement in Virtual Reality 
Evidence suggests that graded exposure, a type of cognitive-behavioural therapy, is among the 
most effective means of reducing pain-related fear of movement, catastrophizing, and disability 
(Grotle et al, 2004a; Martinez et al, 2011; Turner et al, 2002; Vlaeyen et al, 1995). Research 
has shown that excessive fear responses may be signs of a dysregulated anxiety (Parsons & 
Trost, 2014), and that changes in the emotional circuitry of the brain may contribute to stress-
related psychopathology (Parsons & Trost, 2014). Graded exposure therapy provides patients 
an opportunity to discover and correct misinterpretations about cues as warning signals for an 
impeding catastrophe (Grotle et al, 2004a; Heuts et al, 2004; Meulders et al, 2016; Somers et 
al, 2009; Sullivan et al, 2009; Turner et al, 2002). As a result of correcting erroneous 
interpretations, patients will learn which movements or stimuli are safe, which in turn, reduces 
fear (Hermans et al, 2006). Despite considerable promise, existing graded exposure protocols 
are characterized by Woods and Asmundson (2008) as having a number of limitations. First, as 
delivered in the clinical setting, graded exposure protocols are expensive and time consuming, 
relying on trained therapists over an indefinite number of sessions (Vlaeyen et al, 2012). 
Another challenge acknowledged by graded exposure developers is that of patient engagement; 
while empirically most effective, graded exposure does not appear to be a preferred manner of 
treatment by patients and is characterized by a high drop-out rate (ranging from 38-50%) and 
low patient preference rates (Vlaeyen et al, 2012, Woods & Amundson, 2008). Patient non-
adherence is likely due to the anxiety-provoking nature of an intervention designed to challenge 
fearful pain beliefs (Hadjistavropoulos et al, 2004). Third, graded exposure is challenged by the 
generalizability of treatment gains from the treatment clinic to the home environment, as well 
across discrete physical activities (Crombez et al, 2002; Goubert et al, 2002; 2005; Trost et al, 
2005). Finally, fear-avoidance models have been criticized for not taking into account a 
motivational perspective in which goal context factors may affect behavioural performance as 
well (Crombez et al, 2012, Vlaeyen et al, 2009). Together, these limitations provide a 
compelling motivation to enhance graded exposure interventions so that treatment appear more 
attractive to patients, and thereby establishing reliable therapeutic change; and to explore the 
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utility of new technology using principles of graded exposure aiming for development of a cost-
effective physiotherapeutic tool.  
Parsons & Trost (2014) argued that the emergence of Virtual Reality (VR) may be beneficial 
to optimize graded exposure therapy for people with persistent LBP. Thus, in the present thesis, 
a protocol for a VR-intervention was developed with the intention of investigating whether 
graded exposure towards lumbar spine movements in a rewarding and non-threatening virtual 
environment could benefit persistent LBP patients. 
 
1.6.Virtual Reality training 
Virtual Reality (VR) was originally a science fiction idea, which began to emerge in concrete 
form via an immersive film-viewing cabinet created in the 1950s (World Economic Forum, 
2014). For a long time, VR was solely recognized for its entertainment value but over the past 
10 years its application has been expanded to a variety of clinical areas, including pain 
management, physical rehabilitation and the treatment of psychiatric disorders (e.g. phobias, 
post-traumatic stress disorder and anxiety disorders) (Gershon et al, 2000; Zimand et al 2002). 
VR is now defined as “an approach to user-computer interface that involves real-time 
stimulation of an environment, scenario or activity that allows for user interaction via multiple 
sensory channels” (Adamovich et al, 2009). New VR approaches capitalise on recent 
technological advances including improved robotic design, the development of haptic interfaces 
and the advent of human-machine interactions in virtual reality (Burdea, 2003; Merians et al, 
2006), and offers the possibility for delivering patient-specific interactions within the virtual 
environment via head-mounted displays (Figure 3) or with screen-technology (Rose et al, 2005)  




Figure 3: Immersive Virtual Reality equipment with a head-mounted gear and two handheld controllers 
(Image downloaded from: https://bgr.com/2016/03/20/macbook-laptops-virtual-reality/, 24.09.18) 
 
Figure 4 and 5: Non-immersive Virtual Training using a screen- and video-based technology developed 
by Welfare Denmark. Figre 4 and 5 illustrate a training session for an elderly patient in bydel 
Nordstrand, Oslo, Norway. Reference: Fysioterapeuten, Issue 8, 2017. 
 
One advantage of implementing VR technology in rehabilitation is the rapid development of 
different virtual environments and games, which allow for interactive behaviour for patients 
while being monitored and recorded (Bohil et al, 2011). As a relatively new technology, 
immersive VR is still quite expensive. A head-mounted gear (e.g., Oculus Rift) costs 
approximately 500 US Dollars and needs a 1000 US Dollar computer to run the VR-software, 
which currently is quite expensive for rehabilitative purposes. Nevertheless, VR hardware and 
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software show is on the rise, with an estimated global VR industry revenue of 74.82 Billion US 
Dollars by 2021 (Figure 6). 
 
 
Figure 6: Virtual Reality Industry Report, 2017: https://www.greenlightinsights.com/industry-
analysis/2017-virtual-reality-industry-report-spring/  
 
With continued development and economic interest from large technological companies, costs 
related to VR equipment are expected to drop as the technology matures and hits the mainstream 
marked (Li et al, 2011). “Serious gaming” is now a multi-billion-dollar industry (Ma et al, 
2014), and while technological barriers and a lack of content have prevented mass adoption of 
VR,  commercial forces claim that VR and Augmented Reality (AR) are forefront technological 
platforms that eventually will replace smart-phones and tablets. Furthermore, a recent statement 
by the Facebook-VR leader (i.e. one of the leading companies in development of Oculus Rift) 
is that approximately 10 million users are needed using the VR-platform before the 
technological ecosystem can flourish (https://www.cnbc.com/2018/09/26/facebook-vr-leader-
talks-about-the-future-of-virtual-reality.html). Moreover, leading experts in technology refer to 
the “12 Gutenberg Moments” (i.e. rapidly developing fields such as AI and big data, or robotics 
and automation, drones and transportation, VR and AR), which is estimated to have a disrupting 
effect in their respective fields (Silvija Seres, Bergen Næringsråd Årskonferanse, 2017). The 
“fourth industrial revolution”, which is currently emerging, is presumed to challenge many 
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aspects of our societal structure through the advancements of cyber-physical systems (Colombo 
et al, 2017). While certainly of interest, this goes beyond the scope of this thesis. However, 
given the technological landscape, the development and use of technologies such as VR and 
AR specific to rehabilitation may be tools for exploiting resources in the health care system in 
a more sustainable way and may set the scene for a new era in physical therapy rehabilitation. 
 
1.7. From acute to persistent pain management with Virtual Reality 
While VR gaming has shown meaningful clinical effect in the treatment of acute pain, few 
studies have applied VR to persistent pain management. In terms of acute pain management, 
VR-based interventions have been primarily used to distract patients from pain (Hoffman et al, 
2000; 2008; Wiederhold et al, 2014). While distraction is a powerful tool in the case of both 
acute and persistent pain, interventions that rely exclusively on distraction are insufficient to 
address the needs of many individuals with persistent pain, for whom pain is an ongoing (rather 
than temporary) experience (Eccleston & Crombez, 2007). VR-interventions for persistent pain 
are therefore challenged to not just distract individuals but to also incorporate activities 
consistent with real-life patient goals related to tasks in activities of daily living (ADL). For 
example, for persistent LBP patients, the hesitation towards certain movements such as lumbar 
spinal flexion may lead to development of maladaptive and avoidant movement patterns when 
getting dressed and picking up objects from the floor (Thomas et al, 2008). By introducing 
graded exposure training towards various movements in VR, individuals may be encouraged to 
practice progressively more avoided activities with the aim of breaking the association between 
the movement itself and the perceived pain and/or physical harm. With specifically tailored 
virtual environments, interventions may be matched specifically to patients’ interests, goals and 
valued life activities.   
 
1.8. Research on Virtual Reality and persistent Low Back Pain 
Research using VR in rehabilitation is only in its infancy, although publication rates in this area 
are increasing (See Figure 7). Regardless, to date, only one systematic review related to the use 
of VR in medical settings has been published. Dascal et al. (2017) reviewed 11 randomised, 
controlled trials for pain distraction (Carrougher et al, 2009; Hoffman et al, 2008; Kipping et 
al, 2012; Morris et al, 2010; Patterson et al, 2010; Schmitt et al, 2011), eating disorders/obesity 
20 
 
(Cesa et al, 2013, Manzoni et al, 2009), and cognitive and motor rehabilitation (Larson et al, 
2011). The authors suggested that VR is a promising intervention with several potential 
applications in the inpatient medical setting (Dascal et al, 2017).  
 
Figure 7: Annual publication rate for Virtual Reality and Rehabilitation: 1991-2017. 
Systematic searches for “low back pain” + “virtual reality” were completed in Pubmed, Google 
Scholar, EMBASE, Medscape, Cochrane, and Clinical Trial Gov., from August 2016 to 
October 2018. The term “virtual reality” included both immersive (head-mounted gear) and 
non-immersive (screen) technology, although we were most interested in the use of immersive 
head-mounted VR equipment. Results of the searches found that there have been no systematic 
reviews or meta-analysis published for the use of VR in persistent LBP to date, and only a 
handful of clinical trials were found across all available search engines. 
More specifically related to the present thesis, only one randomised clinical study (n=52) by 
Thomas et al. (2016) has investigated the feasibility of a VR-dodgeball game for kinesiophobic 
non-specific persistent LBP patients. Thomas et al. found that although VR-dodgeball (3 
sessions of 15 minutes each) did not elicit significant group differences in lumbar flexion at 
post-game testing, the results indicate that individuals with persistent LBP and high fear levels 
can be encouraged to increase lumbar spine flexion within gameplay sessions. They concluded 
that the proof-of-concepts study demonstrate that virtual dodgeball is safe, feasible, and capable 
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of shaping changes in lumbar spine flexion during gameplay (Thomas et al, 2016). In addition, 
a published phase 2 randomised controlled trial protocol by France & Thomas (2018), aims to 
evaluate Virtual Immersive Gaming to Optimize Recovery (VIGOR) intervention in people 
with persistent LBP. However, at the time of this thesis preparation, the research is ongoing.  
Results for non-immersive VR-studies such as screen technology (Kinect, Wii Fit, etc) are also 
interesting to consider, and in total, six articles have been published in the time period 2011 – 
2016. In 2016, Zadro et al., published a protocol paper for a video-based exercise for older 
people (n=60) with persistent LBP, a feasibility randomised controlled trial (GAMEBACK 
trial). However, results are not yet available. Su et al. (2015), tested a VR-based LBP 
rehabilitation system utilizing wireless sensor technology in 20 participants, in a system design 
and user-acceptance analysis. Roosink et al. (2015), assessed the perception of trunk 
movements in military personnel (n=30) with persistent non-specific LBP using a virtual mirror 
in 30 participants. Kim et al. (2014), investigated the effects of VR-based Wii Fit Yoga-game 
on physical function in 30 middle-aged female LBP patients. Additionally, two trials were 
found on the Clinical Trial Gov website and appear ongoing (no results published): “Virtual 
Reality and pain perception during exercises for patients with persistent non-specific LBP” 
(Matheve et al, 2016), and “Analgesic effect of a prototype device of VR in a population of 
patients with persistent LBP (REVLOC)” (Poiraudeau et al, 2011).  
In summary, the systematic search reveals that research in the field of VR rehabilitation in 
persistent LBP is scarce. Phase 1 and phase 2 clinical trials are needed, followed by rigorous 
testing in randomised controlled trial study designs. Such testing will allow for full scientific 
evaluation which can then inform translation to clinical practice. RC 
 
1.9. Opportunities and challenges with Virtual Reality 
1.9.1. Opportunities with Virtual Reality for Low Back Pain rehabilitation 
The ability to instantly transport the patient into a virtual world for the purposes of distraction 
and exposure to a feared situation makes VR a tremendously powerful tool (Trost, 2015). 
Through immersive multimodal stimuli (i.e., visual, auditory, tactile and/or even olfactory), VR 
may be used to engage the patients in immersive gaming to actively achieve valued life-goals 
(Li et al, 2011). With an appropriate virtual environment, immersive VR training can provide a 
feeling of moving freely in a virtual space, and the tasks may give the patient a sensation of 
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achievement and empowerment. VR-technology may also be used to capture and store metrics 
that cannot easily be detected by an observer (e.g. with movement sensors), which can be used 
to facilitate motor learning. Additionally, the development of virtual environments may be used 
to deliver meaningful and relevant stimuli for active rehabilitation of valued life activities 
(Weiss, Kesher & Levin, 2014), and further, it may address maladaptive movement behaviours. 
Studies by Thomas et al (2007; 2008a; 2008b) has repeatedly shown that LBP patients with 
high fear specifically avoid flexion of the lumbar spine, and subsequently, that avoidance (or 
inactivity) may contribute to shortening of peri-articular connective tissues change in the 
surrounding musculature (Hides et al, 1995; 1996; Lieber et al, 2002). A case-controlled study 
(n=14) by Karayannis et al. (2013) demonstrated that although weakly related, pain-related fear 
of movement was associated with trunk stiffness in people with persistent LBP. Thomas et al. 
(2016) hypothesize this may increase the risk of injury if a person is exposed to “common, 
unexpected environmental challenges” (e.g., missing a step or slipping). Nevertheless, whether 
tailored training in VR may motivate for amelioration of avoidance behaviour and increase 
physical capacity, remains to be investigated. However, protocols for graded exposure training 
as suggested by Parsons & Trost (2014) appears to be promising for this patient group. 
Further, research shows that LBP patients may fail to generalize “safety learning” across 
contexts or physical activities during conventional training tasks (Crombez et al, 2002). For 
example, a patient may learn that bending to tie a shoe is safe for the back, but may hesitate to 
perform a similar amount of lumbar flexion for a different task (e.g., picking up a piece of 
clothing on the floor). Practicing movement across different activities and contexts (with and 
without VR) may therefore be a key to treatment success (Trost et al, 2015). We know that 
transfer is a key concept of learning, and that virtual environments used to train complex skills 
in surgical, flight, or military situations have demonstrated that it is possible to learn skills in 
virtual environments and then transfer this learning into skilled performance in the real world 
(Bossard et al, 2008; Holden, 2005). According to Rose et al. (2000), transfer is dependent on 
the virtual environment and cognitive processing required for task performance being similar 
to the real-world tasks, and may be facilitated if the patient is required to “adapt to changing 
demands, problem-solve, learn from mistakes, simplify and segment tasks, and repeat various 
complex tasks in various contexts” (Bossard et al, 2008). 
Finally, adherence to exercise and/or therapeutic recommendations are important in physical 
rehabilitation as patients are often required to change behaviour over time to achieve 
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improvement from a multidimensional LBP management approach. Adherence to home-based 
exercise commonly ranges between 50 – 70% (Friedrich et al, 1996; Medina-Mirapeux et al, 
2009), and as previously mentioned, adherence to graded exposure therapy ranges from only 
30-58% (Linton et al, 2008; Woods & Amundson, 2008). Whether new technology may 
improve these numbers, this remains to be investigated. However, gaming interventions report 
strong retention and adherence rates, reduced perception of effort and fatigue, as well as 
enjoyment of exercise-related activities (Warbuton, 2013). Therefore, gaming interventions 
should be considered in rehabilitation as we strive for better clinical outcomes (which would 
be predicted by improved adherence) as well as a more cost-effective and sustainable health-
care system. 
 
1.9.2. Challenges with Virtual Reality in Low Back Pain rehabilitation 
While VR training may have a positive impact on a variety of domains, concerns about its safety 
and potential danger to health are critical to consider. Beyond transient motion sickness and 
nausea that can be caused by disconnect in vision and movement (primarily related to current 
technological limitations), long-term effects such as addictive behaviour need to be carefully 
investigated and avoided. Current limitations with VR-gaming in rehabilitation are also related 
to costs, availability, technical competency, and the lack of evidence-based protocols or 
research investigating its effectiveness. In terms of practicality, non-immersive screen 
technology may require less set-up and effort to provide a patient with an opportunity to interact 
with the virtual environment (Weiss, Keshner & Levin, 2014). However, to date there is still 
no evidence published regarding whether immersive or non-immersive virtual environments 
provide the most cost-effective alternative, given that they may have differing clinical 
effectiveness. Such clinical and cost consideration are important for clinicians when exploring 
the wide variety of both immersive and non-immersive equipment available on the market. 
Further, individual differences related to acceptability (e.g. immersive tendencies, 
technological literacy, socioeconomic status), may modulate treatment success and thus must 
be explored (Trost et al, 2015). It is also unclear whether advantages of VR over real-world-
training exist, and if so, an explanation of precisely what these advantages are lacking (Weiss, 
Keshner & Levin, 2014). Future research needs to investigate whether we can capitalize on 
something unique with VR training, or whether VR training is merely more effective because 
of the entertaining nature that keeps patients more engaged and motivated throughout the 
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rehabilitation. Thus, VR training parameters associated with optimal transfer to real-world 
functional improvements, remain to be discovered – such research is preferably completed 
using a person-centred approach. While aforementioned limitations exist, the potential 
favourable opportunities afforded by such technology undoubtedly warrant further 


















2.0. Method  
2.1. Purpose of the study and research hypothesis 
VR-training is a new and innovative intervention that has not yet been fully explored in 
persistent musculoskeletal disorders. Some forefront rehabilitation centres in Norway (e.g. 
Sunnaas Rehabilitation centre and Sykehuset Innlandet) have been the first to utilize VR 
training in musculoskeletal rehabilitation in Norway, but to date, only one feasibility study from 
the United States (U.S.) by Thomas et al. (2016) has investigated a VR-intervention for non-
specific persistent LBP patients with pain-related fear of movement. As the initiators of the first 
Norwegian VR study, we hypothesize that VR-technology may play an important role in patient 
management and education in the future, and that we should start to explore how it may 
facilitate learning in person-centred persistent pain management. The purpose of the study was 
therefore was to evaluate whether Virtual Reality (VR) training had an effect on pain intensity 
and pain-related fear of movement, pain catastrophizing and pain anxiety symptoms in 10 non-
specific persistent LBP patients with pain-related fear of movement. The underlying rationale 
for the study is based on findings from health technology, neuroscience, pain science and 
behavioural research.  
The primary research hypothesis was that a VR gaming intervention would reduce pain 
intensity (H1), and the secondary research hypothesis was that VR gaming intervention would 
reduce pain-related fear of movement, pain catastrophizing and pain anxiety symptoms (H2). 
Pain intensity was measured using a Numeric Rating Scale (0-10 NRS), and pain-related fear 
of movement, pain catastrophizing and pain anxiety symptoms were measured using items from 
the Tampa Scale of Kinesiophobia (TSK), the Pain Catastrophizing Scale (PCS) and the Pain 
Anxiety Symptoms Scale-20 (PASS-20). The independent variable of the study was VR 
training, while the primary dependent variables included registrations of daily permutations of 
pain intensity and pain-related fear of movement, pain catastrophizing and pain-anxiety 
symptoms. To evaluate whether VR training resulted in a significant reduction in the above 
outcome measures (as hypothesized), the difference between the baseline daily outcome scores 
and the daily outcome scores during the intervention period (n=35 measures for each 
participant) would have to be large enough to reject the null hypothesis (H0), i.e. falsify the 
assumption that the two phases had identical distributions. The secondary dependent variables 
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included the secondary outcome measures (see below), which were analysed via calculating the 
percentage change between baseline and follow-up in each participant. 
 
2.2. Single-Subject Experimental Design 
In science there are two main research paradigms: quantitative and qualitative. A specialised 
type of quantitative study design is that of the single-subject paradigm. In the present study, a 
sequential, replicated, randomised single-subject experimental phase design (SSED) with 
multiple measurements was used. An SSED can be used as the first step in the preparation of a 
large-scale trial (e.g. ‘randomised controlled trial’ or RCT) or it may provide an empirical 
generalizability test in one’s own clinical practice of findings known from large-scale research 
(Onghena, 2005a). The SSED, “single-case design”, or “N-of-1 RCTs”, can be broadly 
categorized into two main types: phase designs and alternating designs (Michiels et al, 2018). 
We used the former, which divides the sequence of measurement occasions into separate 
treatment phases, and each phase includes multiple (≥5) measurements (Edgington, 1975, 1980; 
Onghena, 1992). We aimed to measure each participant’s response to the VR gaming 
intervention with an AB-phase design (i.e. phase A = baseline, and phase B = treatment). In the 
study, a 7-day follow-up phase was also used. A study with a withdrawal period may be 
commonly referred to as an ABA-design. However, since the treatment in question is 
considered “irreversible”, that is, its’ effects are unlikely to discontinue once treatment has 
ceased, the term AB-design is used. 
It should be acknowledged that history, maturation bias and statistical regression to the mean 
are three important threats to the internal validity in a SSED. History bias refers to the 
confounding influence of external factors on the treatment effect during the course of the 
experiment (e.g., events or changes in a participant’s life that prior to or during the 
intervention). Maturation bias refers to changes within the subject during the course of the 
experiment that occur as a function of the passage of time and are unrelated to the treatment 
effect (Carter & Lubinsky, 2017). Regression to the mean is a widespread statistical 
phenomenon, that may occur when an extreme group is selected from a population based on 
the measurement of a particular variable. When a second measure is taken from the same group, 
the second mean will be closer to the population mean, which may be mistakenly attributed to 
a treatment effect (Morton et al, 2005). Several methodological features have been proposed to 
increase internal validity within an SSED, including: random assignment of AB-phase duration, 
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replication of multiple AB-design across participants, and using adequate statistical techniques 
(Michiels & Onghena, 2018). In the present study, an attempt to maximize internal validity via 
study design was made. Firstly, the design was made more robust by being replicated across 
several participants. The two ways one can replicate in an SSED, is simultaneously or 
sequentially (Onghena & Edgington, 2005b). Considering that this was an innovative approach 
to LBP management, we chose a sequential replication, which allowed us to carry out and test 
the same design for several patients. Secondly, sequential refers to the replications being carried 
out one by one. In other words, the design is repeated separately for each patient (de Jong et al, 
2012; Onghena et al, 2005a). Thirdly, we used random assignment of phase duration length (for 
baseline and intervention), while standardising the total duration of both phases between 
participants. Indeed, the benefits and importance of random assignment of the different phases 
are emphasized in the recent CONSORT extension for reporting N-of-1 trials (Shamseer et al, 
2015; Vohra et al, 2015), in addition to the single-subject reporting guideline in behavioural 
interventions statement for making valid inferences (Tate et al, 2016). One argument is that the 
lack of random assignment of phase duration in a SSED makes it more difficult to rule out 
alternative explanations that may weaken the internal validity of the design (Dugard et al, 2012; 
Dugard, 2014; Edgington & Onghena, 2007; Heyvaert et al, 2017; Kratochwill & Levin, 2010). 
Thus by randomising the phase duration, it is more likely that any change detected is due to the 
start of the intervention.  
In the present study, the combined duration for the baseline and intervention phase was chosen 
to maximise the number of baseline measures and interventions applied while minimising 
participant fatigue (due to daily measures). For all participants, the baseline (phase A1) and 
intervention phase (phase B) lasted 28 days, and the follow-up (phase A2) lasted for 7 days. To 
randomise baseline duration for all participants, a computer-generated random table was used 
(Appendix 1). The time window for randomisation of the baseline duration was pre-set based 
on earlier studies using a similar design (de Jong et al, 2012), with a baseline ranging from 5-
14 days and a treatment duration ranging from 14-23 days (the latter allowing a minimum of 6 
and a maximum of 9 VR treatments). Finally, each patient was then observed repeatedly (as 
with a longitudinal or time series design), and daily self-reported measures were collected 




2.3. Strengths and limitations with the design 
The AB-design is the most basic and practically feasible experimental designs for evaluating 
treatments in single subject research (Michiels & Onghena, 2018). However, scarce attention 
has been paid to single-subject experiments as a useful and valid strategy for pain management. 
This is unfortunate because single-subject experiments may be ideally suited to “customize” 
treatments, or “to build, fit, or alter treatments to individual specifications” (Onghena, 2005a). 
SSEDs are cheap, relatively easy to execute, provide a robust design for a pilot study, and help 
to validate clinical practice. SSEDs can be considered to have rigorous designs due to multiple 
measurements that strengthen the validity of the design. Therefore, SSEDs may play a key role 
when evaluating novel treatments that do not yet have evidence for their effect (i.e., when 
performing a randomised trial would not yet be recommended). Accordingly, we would classify 
the present study as a phase 2 clinical trial, but with a limited number of participants compared 
to recently developed guidelines (UK Cancer Research, 2015; National Health and Medical 
Research Council, Australia, 2015).  
Although widely used, the AB-design has received criticism for its low internal validity 
(Kratochwill et al, 2010; Shadish et al, 2002; Tate et al, 2016; Vohra et al, 2015). Several 
authors have rated the AB-design as “quasi-experimental” or even “non-experimental” because 
a lack of a treatment reversal phase and control group leaves the design vulnerable to the 
internal validity threats of history and maturation (Kratochwill et al, 2010; Tate et al, 2016; 
Vohra et al, 2015). While some criticize the design, others (e.g. Michiels & Onghena, 2018) 
argue that a randomized AB-phase design can be used as a basic experimental design for 
situations where this design is the only feasible way to collect experimental data (e.g., when 
evaluating treatments that cannot be reversed due to the nature of the treatment or because of 
ethical concerns). Such is the case in the present thesis, where the effects of treatment are 
unlikely to be reversed solely due to removing the intervention. Michiels & Onghena (2018) 
argue that in this situation the threats of history and maturation have to be taken into account 
and acknowledged when considering the results. While important to consider, Kratochwill et 
al. (2010) suggest that designs with multiple AB-phases (e.g. ABAB) offer better protection 
from threats to internal validity than only AB designs, the internal validity of the basic AB-
design can be strengthened via study design features and through adequate statistical analysis, 





Participants were included in the study based on pre-specified eligibility criteria (See Table 1). 
We recruited 14 patients from waiting lists in primary health care through the Outpatients Spine 
Clinic at Haukeland University Hospital, Bergen. To be included in the study, a minimum score 
of 25/52 on the Norwegian version of Tampa Scale for Kinesiophobia (TSK-11) and a minimum 
pain NRS score of 4/10 for the past two weeks was required. Ethical approval was attained from 
the University of Bergen and the Regional Ethics Committee of Western Norway 
(2017/1199/REK vest) (Appendix 2). Table 1 shows an overview of inclusion and exclusion 
criteria for the present study. 
 
Inclusion Criteria Exclusion Criteria 
Low back pain ≥ 3 months Not fully sick listed for more than 6 months 
Age between 18-65 years Ongoing treatment from other therapists (e.g.: 
physiotherapist, manual therapist, chiropractor, 
osteopath, ‘naprapat’ or other). 
Localized pain from T12 to gluteal folds, 
provoked with postures, movements and 
activities. 
Specific LBP diagnosis (radicular pain, disc 
herniation, spondylolisthesis, stenosis, modic 
changes). 
Pain intensity ≥4/10 on Numeric Rating Scale 
(NRS), lasting ≥14 days 
Acute exacerbation of LBP at the time of testing 
(to avoid regression to the mean). 
 
 
Minimum score on Tampa Scale for 
Kinesiophobia (TSK-11 Norwegian Version): ≥ 
25/52. 
Visual disorders, dizziness and/or Benign 
Paroxysmal Positional Vertigo (BPPV). 
 Other:  
- Any lower limb surgery in the last 6 months 
- Previous surgery involving the lumbar spine 
- Currently pregnant or less than 6 months 
post-partum 
- Diagnosed psychiatric disorder 
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- Widespread constant non-specific pain 
disorder 
- Active rheumatoid arthritic disease 
- Progressive neurological disease 
- Serious cardiac or other internal medical 
conditions 
- Malignant diseases 
- Contradictions to general exercise. 
Table 1: Overview over inclusion and exclusion criteria 
 
2.4.1. Key inclusion criterion 1: TSK-11 Norwegian Version 
One of the underlying hypotheses of the present study was that patients with maladaptive pain-
related fear of movement could benefit from a VR intervention that aimed to expose participants 
to lumbar spine movements. TSK-11 score level recommended by Neblett et al. (2013) were 
used to determine cut-off levels for participation in the study: subclinical levels (≤23), mild 
levels (23-32), moderate levels (33-42) and severe levels (43-52). We first aimed to use a pre-
determined score of ≥33/52 (including moderate and severe level) on TSK-11 Norwegian 
version. However, in conversations with the Outpatient Spine Clinic regarding their typical 
patient referrals, it was decided to recruit participants with at least “mild” levels of pain-related 
fear in order to recruit sufficient participants during the available Masters time period.  
 
2.4.2. Key inclusion criterion 2: pain NRS-ratings ≥ 4/10 over the past 14 days. 
Another important inclusion criterion for the present study, was that NRS had to be ≥ 4/10 over 
the past 14 days for the patients to be included in the study. This criterion was important to 
reduce the chances of a “floor effect” (i.e., insufficient ability to detect any changes in pain 
because of low baseline levels) that would be compounded by history bias, maturation bias or 




2.5. The intervention – Tailored VR-training  
Inspired by health technology, neuroscience, pain science and behavioural research, we 
conducted a SSED with 10 non-specific persistent LBP patients with a tailored VR training 
intervention. The aim was to gradually expose patients to movement in different VR-games, 
tailored to their daily measures of pain intensity, pain-related fear of movement, pain 
catastrophizing and pain anxiety symptoms. Three different VR games were chosen and tested 
by MS and TFL, and a protocol for “easy”, “medium” and “hard” levels was developed (Table 
2). As Thomas et al. (2016) argues, the fear-avoidance model posits a generic avoidance of all 
forms of movement that are perceived as threatening, and it is repeatedly shown that individuals 
with LBP that have high levels of fear specifically avoid flexion of the lumbar spine (Thomas 
et al, 2007; 2008a; 2008b). Thus, trunk flexion was a key movement targeted in the present VR 
intervention. All participants started at an “easy” level in all three VR games, with natural 
clinical progression if they showed signs of a reduction in pain intensity, pain-related fear of 
movement, pain catastrophizing and pain-anxiety symptoms.  
 
Difficulty Level Amount of movement required 
Easy Level Targets were approximately between head and solar plexus height, patients 
required minimal to little lumbar flexion to play the VR games. 
Medium Level Targets were approximately between shoulder and hip height; some trunk and 
lumbar spine flexion was required to play the VR games. 
Hard Level   Targets were approximately between solar plexus and middle thigh height, 
patients needed to either bend their knees and/or flex their trunk and lower 
back to play the VR games. 
Table 2: Difficulty levels in the VR games 
 
2.5.1. The VR games 
Patients were encouraged to move as freely as possible in the virtual world, and reported pain 
intensity and fear-levels during and after each VR session (Appendix 3). Consistent with the 
aims of a phase 2 clinical trial, we were also interested in whether participants experienced 
some side effects from the intervention. Therefore, participants also reported any discomfort 
and amount of nausea during and after each intervention. The most important clinical tenet was 
their feeling of safety and autonomy during each VR gaming intervention, and we informed 
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them that we could both increase or decrease the difficulty levels during the session. All patients 
began exercising at “easy” level during VR training number 1. At each session, the patients 
played three different VR games for 10 minutes each, with a 2-3 minutes breaks in between, 
for a total of 30-45 minutes of VR training per session. A description and overview is provided 
in Table 3, and screenshots of the different VR-games are shown in Figure 8-16. 
 
VR game Description 
HoloBall HoloBall is a fun and entertaining squash game that can be adjusted in terms of 
height-, width-, room size, ball size and speed, and the opponent’s reaction speed. 
The patients warmed up in the “Zen”-level, playing squash for a few minutes, and 
subsequently started playing against a computer-generated contestant in 
“Campaign”-level – “Easy”, “Medium”, or “Hard” level.  
RoBow Agent RoBow Agent is a software game developed specifically for this project (by another 
masters student - TFL). In this 10-minute game the player is an agent on a space 
station, equipped with either a bow or a gun, and must defend the space station. 
When the player runs out of ammunition, he/she have to bend forwards and/or rotate 
the trunk to pick up objects in a pre-defined height. The amount of forward flexion 
and rotation can easily be adjusted in real-time to each patient by the clinician, to 
fit an “easy”, “medium”, or “hard” level. 
HoloDance HoloDance is a dragon-based VR game where the patient plays against a dragon, 
who hides in different environments (under water, the desert, or in the jungle). In a 
rhythmic fashion, the dragon sends out lightning fireballs, which the player must 
catch with one or two shields (the hands). The player must move the arms, trunk 
and lower back to catch the lightning fireballs to earn points and progress to the 
next level. There are many different levels in this game, which can be individually 
adjusted in real-time. 





Figure 8: Zen settings with adjustments possible (for warm-up) in Holoball 
 
 




Figure 10: Screenshot of animated player in Holoball 
 
  
Figure 11: One of the tasks in RoBow Agent is to reach forward and pick up objects. These objects can 





Figure 12: A player firing an arrow to hit a moving object in RoBow Agent 
 
 
Figure 13: Using two guns to hit moving targets in RoBow Agent. When running out of ammunition, one 
has to locate and collect new ammunition somewhere in near proximity, and must flex or rotate the 





Figure 14: One of the first levels in Holodance, where one must catch lightning fireballs with two shields 
 
 





Figure 16: Underwater-level in Holodance 
 
2.6. Equipment 
Immersive VR technology includes powerful computers to run the software, head-mounted 
displays, body tracking sensors, specialized interface devices and real-time graphics to fully 
immerse the user in a computer-generated simulated world that updates in a natural way 
consistent with head and body motion (Lange et al 2009; 2012). In the present study, we used 
an Oculus Rift with a head-mounted gear and hand-held controllers to track movement in space 
(Figure 17). System requirements include an Intel Core i5-4590 or AMD FX 8350 equivalent 
or better processor, a NVIDIA GeForce GTX 1060 or AMD Radeon RX 480, equivalent or 
better graphics. In addition, 4 GB RAM, 1x HDMI 1.4 port, and operating system from 
Windows 7 SP1, 8,1 or 10. All hardware was borrowed from SimArena at Western College of 
Applied Sciences in Bergen, Norway, while software was either bought from Steam 
(https://store.steampowered.com/) or developed by a master’s student (TFL) in Software 





Figure 17: Oculus Rift headset from: https://www.oculus.com/  
 
2.7. Data collection 
2.7.1. Primary outcomes measures 
Daily measures were collected over a total period of 35 days in order to investigate how people 
with persistent LBP responded to the VR interventions, and whether pain intensity, pain-related 
fear of movement, pain catastrophizing and pain-anxiety symptoms changed over time. We 
asked participants to complete daily measures of pain intensity (NRS), and 10 selected items 
from three different questionnaires representing kinesiophobia (Tampa Scale of Kinesiophobia, 
TSK) (Goubert et al, 2004; Kori et al, 1990; Roelofs et al, 2007), pain catastrophizing (Pain 
Catastrophizing Scale, PCS) (Sullivan et al, 1995; Van Damme et al, 2002) and pain-anxiety 
symptoms (Pain Anxiety Symptoms Scale, PASS-20) (McCracken et al, 2002). Based on a 
large database of patients with persistent musculoskeletal pain (Roelofs et al, 2007), the internal 
consistency of these subscales was sufficient to good (Cronbach a = .60, .72, and .73, 
respectively) (de Jong et al, 2012). Participants were instructed to complete the daily measures 
consistently at 8 P.M. throughout the total 35 days.  
The specific items collected daily included TSK-item 1: “I am afraid that I might injure myself 
if I exercise”, TSK-item 3: “My body is telling me that I have something dangerously wrong”, 
TSK-15: “I can’t do all the things normal people do because it’s too easy for me to get injured”. 
The items chosen from the TSK-17 were related to activity avoidance (TSK-item 1), somatic 
focus (TSK-item 3), and activity avoidance (TSK-item 15). All these items have been translated 
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to Norwegian by Haugen et al. (2008). Further, we investigated PCS-item 1: “I worry all the 
time whether the pain will end”, PCS-item 2: “I feel I can’t go on”, and PCS-item 13: “I wonder 
whether something serious may happen”. The items chosen from the PCS are related to 
helplessness (item 1 and 2) and to pain magnification (item 13). Finally, four PASS-item were 
selected, item 3: “When I hurt I think about pain constantly”, PASS-item 4: “I find it hard to 
concentrate when I hurt”, PASS-item 5: I worry when I am in pain”, and PASS-item 10: “I try 
to avoid activities that cause pain”. The items chosen from PASS are related to cognitive aspects 
of stress and anxiety (items 3, 4, and 5) and to escape or avoidance (item 10) (McCracken & 
Dhingra, 2002). The PCS was translated and found to have acceptable psychometric properties 
in terms of comprehensibility, consistency, construct validity, and reproducibility for subacute 
and persistent LBP patients (Fernandes et al, 2012). While PASS-items could only be found in 
English versions (no Norwegian translation available) we chose to include still include the 
PASS-items given their relevance to an intervention aiming to reduce anxiety related to 
movement.  
 
2.7.2. Secondary outcome measures 
Secondary outcome measure questionnaires included the Oswestry Disability Index (ODI) 
(Fairbank et al, 1980; 2000), the Örebro Musculoskeletal Pain Questionnaire Screening 
Questionnaire short form (ÖMPSQ short form) (Linton et al, 2011), Patient Specific Functional 
Scale (PSFS) (Stratford et al, 1995), and the Fremantle Back Awareness Questionnaire 
(FreBAQ) (Wand et al, 2014). Additionally, the Neuro Orthopaedic Institute (NOI)-app 
Recognise™ (http://www.noigroup.com/en/Product/BTRAPP) was used to evaluate motor 
imagery performance (Bowering et al, 2014). Importantly, secondary outcome measures were 
only collected at baseline and follow-up. An overview over primary and secondary data 





Figure 18: Example of data collection for a participant with 9 VR-interventions (VR-interventions 
marked as green arrows during the intervention phase). The x-axis represents days and the y-axis 
represents percentage of total score for the outcome measures. Procedures for data collection are 
marked with red and blue arrows, including red arrows showing the trajectories for the primary daily 
outcome measures (NRS, TSK, PCS and PASS), and the blue arrows showing when the secondary 
outcome measures were taken (only collected at Day 1 and Day 35). 
 
2.7.2.1. Oswestry Disability Index (ODI) 
ODI is a 10-item questionnaire developed by Fairbank et al (1980; 2000) to assess pain-related 
disability in people with LBP. The questionnaire was translated to Norwegian in 2003 (Grotle, 
2003), and validated by Fernandes et al. in 2012. The suggested use is for patients with severe 
or persistent disabilities, but according to Grotle et al. (2004b), the form is also valid for both 
acute and persistent LBP patients, with and without sciatica. The first item in ODI is related to 
pain, while the remaining 9 items are related to function in ADL. Each item is rated on a 6-
point Likert scale. A minimal detectable change is estimated to be 10-12 points (Ostelo et al, 
2008). A study by Saltychev et al. (2017) showed that the ODI has good internal validity 
(Cronbach’s α = 0.85), with an exploratory factor analysis showing that the ODI is a 
unidimensional test specific to measuring functional level. A confirmatory factor analysis 
demonstrated that the standardized regression weights of all ODI-items were relatively high, 
varying from 0.5 and 0.7. The item response theory analysis suggested that 8 out of 10 ODI 
items have a close-to-perfect ability to measure functional limitations in accordance with the 
actual severity of disability experienced by the respondents. Discrimination of all the items was 




2.7.2.2. Örebro Musculoskeletal Pain Screening Questionnaire – Short Form (ÖMPSQ -short 
form) 
The Örebro Musculoskeletal Pain Screening Questionnaire is one of the most widely used 
screening questionnaires for the prediction of patients developing work disability due to LBP 
or neck pain (Linton & Halldén, 1998). It was first developed in 1998 and has been validated 
for use in acute and subacute LBP, but also for neck and shoulder patients, as well as for patients 
with more generalized pain disorders. Grotle et al. (2006) translated the questionnaire to 
Norwegian. A study by Grotle et al. (2007) showed that acute LBP patients with a score higher 
than 112/210 were significantly more likely to develop persistent pain and disability. In 2011, 
Linton et al. abbreviated the original 25-item questionnaire to a 10-item questionnaire. The 
items in the short version are scored 0-10, where 0 refers to absence of impairment and 10 to 
severe impairment, with three items reversed when calculating total score (Linton et al, 2011). 
The reliability of the Norwegian and Swedish version of the original ÖMPQ has been reported 
to be good (Linton & Halldén, 1998; Grotle et al, 2006), and while the correlation between the 
original and short questionnaire was 0.91, the receiving operator characteristic curve was nearly 
identical for the two versions. For LBP patients screened for the risk of developing disability, 
using a cut-off of 50/100 on the short version identified 85% in the occupational sample and 
83% in the primary care sample that developed disability; performance which is comparable to 
that of the full version (Linton et al, 2011).  
 
2.7.2.3. Fremantle Back Awareness Questionnaire (FreBAQ) 
Several lines of evidence suggest that body perception is altered in people with persistent LBP 
(Wand et al, 2015, Kregel et al, 2015). Maladaptive perceptual awareness of the back might 
contribute to the pain experiences as well as serve a target for treatment. The FreBAQ is a 10-
item questionnaire developed to assess back-specific altered self-perception (Wand et al, 2016; 
2014). Although the questionnaire is fairly new and only exists in English to date, it proposes 
some interesting aspects warranting further investigating in persistent LBP patients, and show 
reasonable psychometric properties. A person reliability index of 0.74 and a Cronbach a value 
of 0.80 indicated that the internal consistency of the FreBAQ was adequate (Wand et al, 2014). 
Another study by Wand et al. (2016) show that FreBAQ appears unidimensional with no 
redundant items, has minimal ceiling and floor effects, and that FreBAQ correlated with 
sensitivity, distress and beliefs and were uniquely associated with pain and disability. Pilot work 
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has shown that in persistent LBP, mediated reality resulted in pain relief for only the participant 
with altered back perception (as assessed by the FreBAQ), therefore we felt it relevant to assess 
here.  
 
2.7.2.4. Recognise™  
Left/right discrimination tasks are used for evaluating motor imagery performance using the 
application Recognise™ (Figure 19), a commercially available online software program 
(http://recognise.noigroup.com/recognise). The app was developed in 2016 and using similar 
procedures to the online test. Research has shown that persistent LBP is associated with 
disruptions of the working body schema of the trunk (Bray & Moseley, 2011), which might be 
an important contributor to motor control abnormalities seen in this population. The speed and 
accuracy in Recognise™ are hypothesized to reveal dysfunctional motor imagery performance 
due to cortical reorganisation. Bowering et al. (2014) tested Recognise™ on 1008 participants 
and found that those with back pain at the time of testing were less accurate than healthy 
controls (p=0.027), as were participants who were pain-free but had a history of back pain 
(p=0.01). These results were driven by an interaction such as those with current back pain and 
a history of back pain were less accurate (mean=76% [95%CI: 74-78%]) than all other groups 
(≥84% [95% CI:  83-85%]). Given that the VR intervention aims to have participants complete 
movements of the trunk, we were interested to see if motor imagery performance improved 












Figure 19: Recognise ™  
Accuracy on this task in pain-free individuals is ≥ 80%, while reaction times of 1,6 seconds +/- 
0,5 seconds (Bowering et al, 2014). Accuracy and speed should be reasonably equal for left and 
right side.   
 
2.7.2.5. Patient Specific Functional Scale (PSFS) 
The PSFS was developed by Stratford et al. (1995) and is a brief interview-format questionnaire 
used to assess functional disability and a change in performance for activities of daily living. 
The PSFS has gained wide acceptance over the years, as a component of the set of patient-
specific (aka patient-centred) health related quality of life instruments (HRQoL), which allows 
for individuals to generate their own, unique items for each questionnaire (Jolles, 2005). In the 
PSFS, patients nominate three functional activities that are important to them and with which 
they are experiencing some activity limitation (original metric: a 0-10 scale for each item, where 
0 =  unable to perform activity, 10 = able to perform activity at the same level as before injury 
or problem). Validity, reliability, responsiveness for persistent LBP has been tested for PSFS, 
and studies show that the PSFS was more responsive than NRS and the Roland-Morris 
Disability Questionnaire (RMDQ), and that PSFS is valid for group-level change comparisons 
and between-group discrimination (Horn, 2012). A minimum detectable change (90% 
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Confidence Interval) for average score is 2 points, and 3 points for single activity score 
(Stratford et al, 1995). 
In addition to these five secondary outcome measures, two undergraduate physiotherapy 
students from Western College of Applied Sciences, Bergen, collected pre- and post-measures 
of “Deyo’s 7 myths” (Deyo, 1998) in the first four participants of the study. The questionnaire 
was developed based on the hypothesis that several myths regarding LBP were still believed in 
the general population in Norway, i.e., beliefs that were not concordant with current guidelines 
(Ihlebæk et al, 2003). “Deyo’s 7 myths” will not be included in the data analysis for the master 
thesis, considering we already had pre-selected five other secondary measures that we wanted 
to look further into. All questionnaires related to primary and secondary outcome measures can 
be found in Appendix 4. 
 
2.8. Statistical analysis 
Linear mixed models are powerful and flexible tools, well suited for single-subject designs 
(Winter, 2013). The advantage of using a multi-level linear mixed model is that it provides 
flexibility when accounting for between participant differences in the number of data points 
and thus takes the full data into account. Traditional analysis on group data (i.e. RCTs) will 
perform an average-calculation and disregard daily variation in response to treatment. On the 
contrary, the analysis in the present study provides valuable information on a number of 
measures across each participant throughout the course of a new therapeutic intervention.  
 
2.8.1. Primary outcome measures (Daily measures) 
In the present study we investigated whether there was a significant change between baseline 
and intervention for the daily primary outcome measures (pain NRS, TSK, PCS, and PASS) in 
the participants. In order to derive an effect size and t-value from a linear mixed model, the 
researcher must be willing to make the same assumption as a t-test does, i.e., that all recorded 
observations are independent of each other. We used a multi-level linear mixed model to 
analyse the primary outcome data. The multi-level model regards the replicated case series data 
as ‘nested data’. Thus, individual measurement occasions are nested in cases (the individual) 
and the model takes into account that the measurement occasions are not independent of the 
person in which they are measured. Previous SSED work has used randomization tests; 
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however, such an analysis is best suited when the intervention immediately results in a 
treatment effect. Given our intervention was not expected to immediately change pain/fear, it 
made more sense to evaluate overall differences between baseline and intervention scores, 
taking into account individual variability. The multilevel linear mixed analysis generates a t-
value from which we derived a p-value from the reference distribution table (Appendix 5), 
indicating whether our findings were statistically significant. While the assumption of 
independent data of a t-test is not met, multilevel modelling is still recommended for SSED 
data (Baek & Ferron, 2013) given that the analysis is conservative rather than liberal (more 
chance of a type II error rate than type I) and the reduction in power from using a between group 
comparison is offset by the multiple measures at baseline and intervention (which are treated 
as dependent data). 
For the primary outcome measures, we also evaluated whether participants achieved a clinically 
significant or minimally important change (MIC). We therefore used existing guidelines for 
Minimal Important Change (MIC) or Minimal Clinical Important Difference (MCID) to explore 
our data further, as the terms are used interchangeably. The current consensus states that a 30% 
improvement in pain and functional status from baseline may be considered a clinically 
meaningful improvement when comparing pre- and post-measures (Ostelo et al, 2008). The 
proposed MIC value for NPS-change in LBP is 2,0 points (Ostelo et al, 2008). While there is 
no current consensus regarding the MIC for TSK, PCS and PASS rating scales, if patients 
achieved a 30% reduction in score from baseline to follow-up, we reported it as a meaningful 
change. We based this decision on de Jong’s (2012) study design, who used the same approach 
to determine meaningful change for TSK, PCS, and PASS when investigating graded exposure 
therapy for patients (n=8) with work-related upper extremity pain.  
All statistical analyses were performed with lme4 and R package in SPSS. Bates et al. (2012; 
2014) developed the lm4 package for R (R Core Team, 2012) in SPSS, as it provides functions 
to fit and analyse linear mixed models for single-subject experimental designs. Some of the 
proposed statistical modeling techniques for single-subject experimental designs include: 
interrupted time series analysis, generalized mixed models, multilevel modelling, Bayesian 
modelling techniques and structural equation modelling (Michiels & Onghena, 2018). In the 
present study, a multilevel modeling, or linear mixed model, was used. Further, techniques for 
statistical analysis of randomised AB phase designs can be divided into three subgroups: effect 
size calculation, statistical modeling, and statistical inference. In this study, we chose a 
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statistical modelling technique, which means constructing adequate description of the data by 
fitting the data to a statistical model (Michiels & Onghena, 2018). Additionally, a random slope 
was fitted with the linear mixed model, which means that the size of the treatment effect is 
allowed to vary across participants. Researchers in ecology (Schielzeth & Forstmeier, 2009), 
psycholinguistics (Barr, Levy, Scheepers, & Tilly, 2013) and other fields have shown that 
designs without random slopes are prone to a high Type I error rate (i.e. they tend to find a lot 
of significant results which are actually due to chance) (Winter, 2013), therefore we wanted to 
maximize the random effects structure for primary outcomes measurements in the study. 
Different techniques have been proposed for carrying out the analyses in a linear mixed model, 
i.e., visual inspection of graphs, or statistical modelling. In order to evaluate internal and 
external validity in SSEDs, visual analysis tended to be the “gold standard” for single-subject 
data because of a presumed low Type 1 error rate and consistency across raters (Nelson et al, 
2012). Thus, in the past, many researchers therefore saw little need for statistical aids (as 
described by Nelson et al, 2010, p. 3). However, recent research found that visual analysis of 
SSED data was less accurate and reliable than typically assumed (Nelson et al, 2012). In the 
present study, we have depicted all the primary outcome measurements in graphs to visualize 
change across all participants, but have not included a visual-based analysis. Statistical 
inference is not suggested as a replacement for visual analysis but is rather an aid for enhancing 
reliability and consistency, and for giving researchers and clinicians a means to corroborate 
visual analysis decisions, especially when considering important treatment decisions (Nelson 
et al, 2012). Statistical inference may also provide an empirical “check” for researchers and 
clinicians, either by forcing them to examine data more closely when contrasting decisions arise 
or by reducing the likelihood of overestimating treatment effects (Nelson et al, 2012). Finally, 
it may provide a common metric for discussing effects across participants, studies, and 
treatments (Nelson et al, 2012).  
 
2.8.2. Secondary outcome measures (Non-daily measures) 
Secondary outcome measure changes were analysed by calculating the percentage changes 
scores. The difference between pre-treatment and post-treatment scores was expressed as a 







Participants were recruited from the Outpatient Spine Clinic at Haukeland University Hospital, 
Bergen, Norway over a 6-month period (January to June 2018). A total of 14 participants were 
invited to participate, with 10 participants providing written informed consent and included in 
the study. Data from nine participants were analysed – data from one participant was excluded 
because the baseline pain ratings dropped after screening at the Outpatient Spine Clinic. 
Specifically, the participant rated pain at 4/10 on NRS during screening (26.04.18), but when 
meeting with MS and TFL for enrolment in the study (11.05.18), pain levels had dropped to 
1/10 (Appendix 6). The participant should therefore have been excluded before entering the 
study and thus will be removed from the data analysis. Of the included participants, 8 were 
male and the average age was 44.1 ± 13.2 (range: 28-63). See Figure 20 for a flow chart of 

















Figure 20: Flow chart of study participation 
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TSK ODI ÖMPQ The NOI-app 
Recognise™ 
FreBAQ PSFS 
ID22 Male, 63 years, married, 2 
children. Profession-based 
education (plumber). On 
full sick leave for 5 
months. Been sick listed 
for the same complaint 2-
5x before.  











8/36 Lifting heavy: 4 
Carrying heavy: 3 
Vacuuming: 4 
ID23 Male, 38, married, 4 
children. Primary school 
(runs own company). 
Partial sick leave for 5 
months. Been sick listed 
for the same complaint 
more than 10x before.  
4.83 Lumbar spine, 
bilateral, but 
most pain on the 
left side. Pain of 












16/36 Sitting in excavator: 3 
Sitting in truck: 3 
Sitting in office: 3 
ID24 Male, 31, single. Primary 
school (maintenance work 
with tunnels). Full sick 
leave for 3 months. Never 
been sick listed for this 
complaint before. 















7/36 Driving far: 7 
Certain tasks at work: 5 
Strength training: 7 
ID25 Female, 54, 1 divorced, 1 
child. Profession-based 
education (working in 
health care). On full sick 
leave for 1 year. Been sick 
listed for the same 
complaint 2-5x before.  















24/36 Sitting: 2 




ID26 Male, 47, married, 2 
children. Profession-based 
education (off-shore). On 
full sick leave for 5 
months. Been sick listed 
for the same complaint 
more than 10x.  
6.11 Lumbar spine, 
bilateral, mostly 
right side with 
radiating pain 













4/36 Walking: 4 
Sitting: 4 
Bending forwards: 2 
ID27 Male, 28, single. Primary 
school (truck driver). Not 
sick listed. Been sick listed 
for the same complaint 2-
5x before.  
2.00 Lumbar spine, 
slightly more 









10/36 Working: 4 
Hiking: 6 
Lifting: 6 
ID28 Male, 48, married, 3 
children. Profession-based 
education (car salesman 
and mechanic). Not sick 
listed. Have never been 
sick listed for the same 
complaint before.  
2.07 Lumbar spine, 
bilateral, but 
slightly more 













ID29 Male, 59, divorced, 2 
children. Primary school 
(technician). On full sick 
leave for 5 months. Been 
sick listed for the same 
complaint 2-5x before. 















8/36 Doing the dishes: 0 
Dressing: 4 
Bowling: 2 
ID30 Male, 29, single. 
University education 
(working in IT). Partly sick 
listed for 3 months. Never 
been sick listed for the 
same complaint.  



















Mean ± SD or count, %: 
Female: 1 (11.1%) 
Age mean ± SD (range): 44.1 ± 13.2 (28-63) 
Pain intensity (NRS) baseline mean ± SD (range): 4.96 ± 2.33 (range:1-9) 
Demographic factor: Is the pain intensity present all the time, ID30: “yes”, other participants: “no”. 
Demographic factor: Shift work: ID26: “yes”, other participants: “no”. 
 
Table 4: Demographic and baseline characteristics. Baseline Numerical Rating Scale (NRS) is presented as mean baseline score for all participants. Pain in other body 














3.2. Primary outcome measures 
3.2.1. Pain intensity changes 
The lme4 (Bates et al, 2012) and the R package (R Core Team, 2012) in SPSS was used to 
perform a multi-level, linear mixed effects analysis of the relationship between baseline and 
follow-up for each participant. As fixed effects, we entered pain and baseline duration (without 
interaction term) into the model. As random effects, we had intercepts for each subject, as well 
as random slopes for the effect of pain. There was a statistical reduction in pain intensity levels 
as a result of the intervention (t9,350 = -4.613, p = <0.001). Specifically, the effect estimate for 
pain intensity (NRS) was -1.0240 (standard error = 0.22). That is, pain intensity ratings during 
treatment decreased by an average of 1 point on an 11-point NRS from baseline pain intensity 
ratings. P-values (<0.001) were conservatively derived from the t-value (-4.613) in the analysis 
for 8 degrees of freedom (n-1). Statistical analysis of residual plots did not reveal any obvious 
deviations from homoscedasticity or normality. Figure 21 shows the daily pain score ratings for 












Figure 21: Participants with a MIC for pain intensity (NRS). The dashed vertical lines in blue represents the 
changes between experimental phases. The first period is the baseline, the second is the treatment phase, and the 
third is the follow-up phase. The red dashed vertical lins represents an extended baseline duration for ID25. * = 
pain reduction was greater than the MIC 
 
 
In participants that achieved the MIC for pain intensity (NRS) following treatment, the 
individual response to treatment was variable (See Figure 21, * participants). Some participants 
experienced significant pain relief (ID23, ID24, ID25) while one participant had highly 
fluctuating pain levels throughout the study, but with a gradual reduction in pain as compared 
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with baseline scores (ID29). Similarly, the responses were also variable for participants (n=5) 
that did not achieve a reduction in pain intensity greater than the MIC for the pain NRS. 
Notably, all 5 participants still did experience reduced pain intensity. ID26 had large 
fluctuations in pain levels throughout the study, which gradually decreased by 1.71 points on 
NRS from baseline to follow-up. Two of the participants (ID27 and ID28) had lower mean pain 
intensity scores (NRS) throughout the baseline phase compared to other participants (Table 5), 
which may have contributed to a floor-effect in the primary analysis. In contrast, ID30 had high 
pain scores throughout the study and only a minimal change in NRS (1.07 points change). ID25 
had total pain relief for approximately 6 days before experiencing some days of increased pain. 
Despite two participants (ID26 and ID27) having low NRS scores at baseline of the present 
study, the results for pain intensity (NRS) were still statistically significant. Further, a 
sensitivity analysis (indentical to above) was run excluding those two participants and there 
was still a significant effect of pain (t7,242 = 7.416, p<0.001, effect estimate -1.40, standard error 
0.19). Pain intensity ratings during treatment decreased by an average of 1.4 points from 
baseline on a 11-point NRS. 
When considering the changes in pain intensity from baseline to follow-up (7 days of pain 
measures post-intervention), the results suggest that the effect on pain was maintained or even 
increased (Table 5). 
 






Change, (%), from 
baseline to intervention 
Change, (%), from 
baseline to follow-up 
ID22 5.91 5.96 4.14 -0.02 (-0.33%) -1.77 (-29.94%) 
ID23 4.83 3.23 2.00 -1.52 (-31.47%) -2.83* (-58.59%) 
ID24 3.87 2.20 0.14 -1.68 (-43.31%) -3.73* (96.38%) 
ID25 5.14 2.57 0.85 -2.57 (-50%) -4.29* (83.46%) 
ID26 6.11 5.42 4.42 -0.69 (-11.29%) -1.69 (27.65%) 
ID27 2.00 1.50 1.00 -0.5 (-25%) -1.00 (50%) 
ID28 2.07 1.42 1.00 -0.64 (-30.92%) -1.07 (51.69%) 
ID29 8.20 6.78 4.71 -1.42 (17.31%) -3.49* (42.56%) 
ID30 8.07 7.80 7.00 -0.27 (-3.34%) -1.07 (13.25%) 
Table 5: Change in NRS scores. * = MIC for pain intensity (NRS) 
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3.2.1.1. MIC on the Pain NRS 
The number of participants that experienced a minimal important change (MIC) in pain 
intensity (defined as a NRS score reduction greater than 2.0 points (Ostelo et al, 2008) with 
treatment was considered. In the current sample, four out of nine participants had a pain 
intensity reduction greater than 2.0 points on 0-10-point NRS. Table 5 shows the participant-
specific percentage change scores (Participants with a MIC for pain intensity in Figure 21 are 












3.2.2. Changes in pain-related fear of movement (TSK), pain catastrophizing (PCS) and pain anxiety symptoms (PASS) scores 
The same statistical analysis (as per pain intensity) was performed for pain-related fear of movement (TSK), pain catastrophizing (PCS) and pain 
anxiety symptoms (PASS) was performed using lme4 (Bates et al, 2012) and R package (R Core Team, 2012) in SPSS. As fixed effects, we entered 
TSK, PCS and PASS-values and baseline duration into the model. As random effects, we had intercepts for each subject, as well as random slopes 
for the effect of pain-related fear of movement, pain catastrophizing and pain anxiety symptoms. There was a statistically significant reduction in 
pain-related fear of movement (t9,347 = -8.670, p = <0.0005), pain catastrophizing (t9,347 = -3.45, p = <0.005) and pain-anxiety symptoms (t9,347 = -
8.40, p = <0.0005) from receiving VR-based treatment (compared to baseline levels) for participants in the study (See Table 6 and Figure 22 for 
individual participant outcome).  
  
Changes in TSK scores 
 
Changes in PCS scores 
 





















































ID22 44.0 40.7 14.14 -7.5% -67.86% 16.67 13.02 9.52 -21.89% -42.9% 35 35 35 0% 0 
ID23 75.44 76.8 77.33 +1.8% +2.5% 75.00 78.78 75.00 +5.04% 0% 88.33 85.00 85.83 -3.76% +2.83% 
ID24 55.00 52.25 53.42 -5% -2.87% 32.14 15.41 8.33 -52.05% -74.08% 39.28 23.50 25.71 -40.17% -34.54% 
ID25 40.85 39.80 42.43 -2.57% +3.84% 41.67 11.50 0 -72.40% -72.40% 47.85 23.80 5 -50.26% -89.55% 
ID26 55.33 29.75 22.00 -46.23% -60.23% 25.00 32.45 36.90 +29.8% +47.6% 77.85 77.89 80.00 0% +2.76% 
ID27 33.00 33.00 33.00 0% 0% 8.33 8.33 8.33 0% 0% 25.71 3.33 0.71 -87.04% -97.2% 
ID28 33.00 11.00 11.00 -66.67% -66.67% 0 0 0 0% 0% 12.85 0 0 -12.85% -12.85% 
ID29 0 0 0 0% 0% 8.33 2.17 0 -73.94% -73.94% 35.00 20.00 8.00 -42.85% -77.1% 
ID30 55.00 46.93 44.00 -14.67% -20% 0 0 0 0% 0% 65.71 67.66 60.00 +2.96% +8.68% 
Table 6: Changes in pain-related fear of movement (TSK), pain catastrophizing (PCS) and pain anxiety symptoms (PASS). Reductions in TSK, PCS or PASS scores are marked with 
lighter green backgrounds, while ≥30% reduction from baseline is marked with darker green backgrounds.   
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The effect of treatment on pain-related fear of movement (TSK) was -7.9 (standard error = 0.91) 
for participants in the study. That is, TSK scores during the intervention decreased, on average, 
by 7.9 points from baseline scores. Statistical analysis of residual plots did not reveal any 
obvious deviations from homoscedasticity or normality. The P-value (<0.0005) was derived 
from the t-value (-8.670) with 9 degrees of freedom. Two participants showed more than a 30% 
reduction in TSK scores from baseline (See Table 6). 
The effect of treatment on pain catastrophizing was -3.2 (standard error = 0.93) for participants 
in the study. That is, PCS scores during the intervention decreased, on average, by 3.2 points 
from baseline scores. Statistical analysis of residual plots did not reveal any obvious deviations 
from homoscedasticity or normality. The P-value (<0.005) was derived from the t-value (-
3.453) with 9 degrees of freedom. Three participants showed more than a 30% reduction in 
PCS scores from baseline (See Table 6).  
The effect of treatment on pain-anxiety symptoms scale (PASS) was -9.8 (standard error = 1.2) 
for participants in the study. That is, TSK scores during the intervention decreased, on average, 
by 9.8 points from baseline scores. Statistical analysis of residual plots did not reveal any 
obvious deviations from homoscedasticity or normality. The P-value (<0.0005) was derived 
from the t-value (-8.404) with 9 degrees of freedom. Five participants showed more than a 30% 
reduction in TSK scores both from baseline (See Table 6).  
When considering the changes in TSK, PCS, and PASS from baseline to follow-up (7 days of 
pain measures post-intervention), improvement was maintained or increased. Table 6 provides 
a breakdown of the percentage that TSK, PCS, and PASS ratings changes between baseline and 









Figure 22: Change in pain-related fear of movement (TSK), pain catastrophizing (PCS) and pain anxiety symptoms 
(PASS) for all participants. The dashed black vertical lines represent the changes between experimental phases: 
baseline, treatment, and follow-up phase. The dashed orange vertical line represents an extended baseline duration 
for ID22 and ID25. 
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3.2.2.1. Clinically meaningful changes for TSK, PCS, and PASS ratings 
As shown in Table 6, results for TSK, PCS and PASS scores had a large variation. While some 
participants had an increase in TSK, PCS or PASS scores from baseline, the overall trend was 
a reduction in scores between baseline, intervention and follow-up. ID25 showed the greatest 
overall reduction when combining all three measures. In summary, three participants had a 
meaningful change (≥30% reduction) for pain-related fear of movement (TSK), four 
participants had a meaningful change for PCS, and five participants had a meaningful change 
for PASS. As visually depicted in Figure 22, ID25 showed the most obvious connection to 
phase shift when the VR-based intervention was introduced. Nevertheless, all participants 
showed a statistically significant effect for pain-related fear of movement (TSK), pain 
catastrophizing (PCS) and pain anxiety symptoms (PASS). A full overview in Figure 22. 
 
3.2.2.2. Change in pain NRS related to number of VR-trainings 
Since the number of VR-interventions were randomized between participants, we were also 
interested in investigating whether the duration of the pre-treatment phase (i.e. baseline) and 
the number of interventions led to a more nuanced result for pain intensity (NRS) ratings. Table 
7 shows that participants who had a shorter pre-treatment phase (5-8 days) and a higher dosage 
of VR-trainings (8 or 9) had a MIC. The remaining participants who did not have a MIC, had 
longer pre-treatment phases (10-14) and a lower dosage of VR-training. Meanwhile, ID26 had 
an ‘intermediate’ pre-treatment phase (9 days) and dosage of VR-trainings (8 VR-trainings), 
but no MIC (although close at -1.69). A discussion on these results are provided in subsection 
4.2.1. 
ID 
Duration of baseline 
(days) 
Number of interventions 
(descending number) 
NRS change from 
baseline to follow-up 
25 7 9 -4.29* (83.46%) 
29 5 9 -3.49* (42.56%) 
23 6 9 -2.83* (-58.59%) 
24 8 8 -3.73* (96.38%) 
26 9 8 -1.69 (27.65%) 
22 12 7 -1.77 (-29.94%) 
27 10 7 -1.00 (50%) 
30 13 6 -1.07 (13.25%) 
28 14 6 -1.07 (51.69%) 
Table 7: The implication of number of VR-trainings on pain intensity (NRS) reduction. The 
table shows that participants with 8 or 9 VR-trainings had a greater reduction in NRS score. * 
= MIC for NRS. 
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3.3. Secondary outcomes measures 
In the secondary outcome measure analysis, a comparison of scores from baseline to follow-up 
(post-intervention) was performed. The change in outcome for each participant was calculated 
as a percentage improvement for ODI, ÖMPSQ short form, FreBAQ and Recognize™ from 
baseline. Change scores are presented in Table 8, while a full overview of scores for secondary 
outcome measures can be found in Appendix 7 and Appendix 8. Unfortunately, one 
questionnaire, PSFS, had to be excluded from the analysis due to missing data at follow-up 
(Appendix 9). Of all participants in the present study, ID25 was the only participant with a MIC 
in pain intensity (NRS), and ≥30% reduction in pain catastrophizing (PCS), pain-anxiety 
symptoms (PASS), and reduced scores in all secondary outcome measures.  
 
 
3.3.1. Oswestry Disability Index 
In total, 7 out of 9 participants had a reduction in ODI scores. Four out of 9 participants (ID22, 
ID24, ID25 and ID26) showed a MIC, i.e. 10% reduction in ODI score from baseline to follow-
up (Fairbank & Pynsent, 2000). One participant (ID26) moved from the category 70% disability 
(crippled) at baseline to 52% (severe disability) at follow-up. A complete overview of the 


















ID22 -14% -13.5% -75.2% +47% -59% +30% -20% 
ID23 -4% -19.3% -31.3% +60% -15% 0% -15% 
ID24 -14% -26.1% +29.0% +20% -11% +5% 0% 
ID25 -18% -20.0% -79.2% -34% -10% +30% +25% 
ID26 -18% +7.6% +25.1% +11% -29% +5% -5% 
ID27 -4% -33.3% -90.0% -19% -27% -5% -25% 
ID28 -2% +23.8% 0.0% -11% -17% +5% +5% 
ID29 +2% -17.2% -12.3% -22% -55% -15% -25% 
ID30 +12% -7.1% +44.0% -25% -25% 0% -10% 
 
Table 8:  Secondary outcome measures: change (%) from baseline. Reduction in ODI, ÖMPSQ short form, 
FreBAQ and Recognize ™ scores are marked with lighter green backgrounds, while reductions (≥10% for 
ODI, and ≥30% for the remaining questionnaires) from baseline is marked with a darker green backgrounds. 
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3.3.2. Örebro Musculoskeletal Pain Screening Questionnaire - short form 
ÖMPSQ short form ranges between 1-100, and a score ≥50 indicates higher estimated risk for 
future work disability (Linton, Nicholas & MacDonald, 2011). In total, 7 out of 9 participants 
had reduced ÖMPSQ short form scores at follow-up. Only ID27 had a ≥30% reduction for 
ÖMPSQ short form from baseline to follow-up. Two participants (ID23, ID29) went from 
above, to beneath, the original cut-off score (50/100) throughout the course of the study (See 
Appendix 7 for more details). 
 
3.3.3. Fremantle Back Awareness Questionnare 
Analysis of the FreBAQ questionnaire data showed variable outcomes when comparing 
baseline and follow-up. In total, 5 out of 9 participants showed a reduction in score, while 4 out 
of 9 showed a ≥30% change in FreBAQ score from baseline to follow-up. However, the change 
scores showed high inter- and intra-case variance, with no consistent direction or trends towards 
a negative or positive change across all 9 participants. Full data is provided in Appendix 7. 
 
3.3.4. Recognise™ 
The Recognise ™ data showed variable outcomes, as shown in Table 8, with the exception of 
performance on “Speed: right side images”, which showed a consistent reduction across all 9 
participants. Data for “Speed left side” and “Accuracy left side” and “Accuracy right side” did 
not show any particular trends. Full data is provided in Appendix 8. 
 
3.4. Compliance with baseline, intervention and follow-up phases 
Significant effort was made to fit participants’ schedules into the present research design that 
involved randomising participants to a variable baseline and intervention duration. With some 
minor adjustments, most participants’ baseline and intervention phases occurred as randomised. 
The randomised baseline duration was implemented for all participants, except for two, who 
were delayed by 1 and 2 days (Table 9). All participants received their randomized number of 
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interventions (between 6 and 9) within the first 28 days of the study as planned. For the 7-day 
follow-up, all participants filled in daily measures for at least 35 days as planned. However, due 
to unforeseen events (work-related issues, vacations and illnesses), some participants were 
unable to meet again at day 35. This resulted in some additional “daily measures” and secondary 
measure assessment was delayed (ranging from 1-5 days) for some participants.  
 




Baseline + intervention duration 
 
Follow-up duration 
 Start  Plan Actual Plan Actual I* Plan Actual 
ID23 08.01.18  6 days 6 days 28 days 28 days 9 7 days 12 days* 
ID26 09.01.18  9 days 9 days 28 days 28 days 8 7 days 10 days* 
ID24 23.01.18  8 days 8 days 28 days 28 days 8 7 days 9 days* 
ID28 26.02.18  14 days 14 days 28 days 28 days 6 7 days 7 days 
ID22 19.02.18  12 days 14 days* 28 days 28 days 7 7 days 8 days* 
ID25 26.02.18  7 days 8 days* 28 days 28 days 9 7 days 7 days 
ID30 23.02.18  13 days 13 days 28 days 28 days 6 7 days 7 days 
ID29 09.04.18  5 days 5 days 28 days 28 days 9 7 days 9 days* 
ID27 15.04.18  10 days 10 days 28 days 28 days 7 7 days 7 days 
Table 9: overview over baseline, intervention and follow-up phase. Note:* =discrepancy and planned and 
actual phase duration marked in red. 
 
3.4.1. Side effects 
Participants did not report any side effects during VR training. One participant (ID26) expressed 
that he did not feel that the VR training was relevant to the specific complaints that he had in 
ADL. This remains one of the challenges with the novel intervention provided in the present 






Overall, this study found that a VR-training program resulted in significant reductions in pain 
intensity (NRS), pain-related fear of movement (TKS), pain catastrophising (PCS), and pain 
anxiety symptoms (PASS) in people with persistent LBP. These improvements were 
maintained or improved following treatment completion (7-day follow-up). This section will 
discuss the influence of methodological features on the study findings and how this impacts the 
interpretation of the present results. Further, this section will discuss the findings, comparing 
the present results to previous literature in the area. Last, this section will discuss the overall 
study strengths/limitations, discuss the implications of this work to future research directions, 
and last, provide a clinical perspective based on these results.  
 
4.1. Methodological features: influence on the study findings and their interpretation 
4.1.1. Influence of study design 
When deciding which study design to implement, performing an SSED or a pilot-RCT were the 
two primary design candidates to choose between. An SSED was eventually chosen given the 
need for a study design to investigate the use of new type of technology, software and protocol. 
The benefit of an SSED is that it allowed us to follow participants with daily measures 
throughout the intervention using a rigorous research method and statistical analysis, as seen in 
other pilot studies developing psychological treatments for pain and medicine (Morley et al, 
2015). The study design also provided insight via daily pain measures on the effect of an 
innovative approach (VR) that eventually aims to provide highly cost-effective interventions in 
the field. Having detailed information about such an intervention is important, given that meta-
analysis have shown that compared with no treatment or treatment as usual, psychological, 
physical, and pharmacological treatments for persistent pain can be effective, but the effects are 
small (Morley et al, 2015); thus rich information about a new intervention can help guide 
refinement. Additionally, the study design satisfied the practical needs for a master’s project 
that has a limited time frame, particularly given the challenges that accompany development of 
a new treatment using innovative technology. For example, as part of the Masters, we needed 
to borrow VR-equipment for the study, find appropriate software and IT-competence, develop 
a protocol for the study, find a test location that matched the technical demands, and recruit and 
test participants. However, limitations relevant to the design exist: we do have measures of 
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effect size relevant to a control group (and thus external generalizability) that occur with RCT’s 
(the “gold standard” design).  
The present phase 2a clinical trial (i.e. proof of concept study), evaluated the efficacy (and side 
effects) of VR training in people with persistent LBP. Use of this study design, thus allowed us 
to provide proof of concept evidence that VR training results in a statistically significant 
reduction in pain intensity (NRS), pain-related fear of movement (TSK), pain catastrophizing 
(PCS) and pain-anxiety stress symptoms (PASS), and that we therefore could reject the null 
hypothesis (H0). If this intervention was to be further investigated, the next step would be to 
perform a phase 2b clinical trial whose aim is to determine the correct therapeutic dosage of 
interventions. As will be discussed further in subsection 4.2.5., the present study demonstrated 
that a higher dosage (≥8) of VR-sessions compared to Thomas et al.’s feasibility study (2016) 
may be beneficial to achieve a statistically significant effect. Further, a phase 3 clinical trial, 
would be relevant to compare the VR-intervention with another treatment alternative using a 
between-subjects design (Cancer Research UK, 2015, National Health and Medical Research 
Council, Australia, 2015). We found it reasonable and ethically sound to skip the first testing 
phase for clinical trials (i.e., testing the protocol on healthy participants,) since the protocol we 
developed could be easily adjusted to provide different levels of exposure to movement to 
ensure that participants were not placed in situations that could be harmful.  
 
4.1.2. Considerations relevant to participants recruited 
Participants were screened by a rehabilitation team consisting of general practitioners, 
physiotherapists, occupational therapists and nurses at the Outpatient Spine Clinic from 
Haukeland University Hospital, Bergen. Participants are therefore representative of the type of 
LBP patients commonly seen in primary health care. This provides us with confidence that our 
results are relevant to patients that are seeking care for their LBP. The sample was heterogenous 
with varying age, education level, duration of LBP (≥3 months) and duration of sick-listing due 
to LBP. Most participants were men (89.9%), which is merely an unintended result of 
consecutive sampling of patients entering the Outpatient Spine Clinic in the time period January 
to June 2018, since we did not randomise participants for enrolment in the study. As we 
continue to rely more on games for education and training in health care, software developers 
need to ensure that future health technology games are attractive and motivating for both men 
and women of all ages (Veltri et al, 2014).  
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4.1.3 Inclusion and exclusion criteria 
All inclusion and exclusion criteria were upheld according to the protocol (Subsection 2.4, 
Table 1), with two exceptions, 1) one of the included participants’ NRS score was too low (did 
not meet formal eligibility criteria), and 2) minor adjustments in the eligibility cut-off score on 
TSK-11 were made to ensure sufficient participant recruitment.  
Ten participants were recruited for the study, nine were considered eligible for data analysis. 
One participant (ID21) was excluded from data analysis due to low pain intensity (NRS) score 
(1/10) at baseline (Appendix 6). Further, all remaining nine participants had 4/10 on NRS at 
screening at the Outpatient Spine Clinic. However, for two participants, the pain intensity had 
continued to drop from screening and throughout enrolment in the study, which means that 
ID27 had a mean baseline score of 2.0 points, and ID28 had 2.07 points (Table 5, Subsection 
3.2.1.). This may have led to less variable scores throughout the study, and a potential “floor 
effect” compared to other participants. In Figure 21, these two participants account for two of 
the five participants who did not show any MIC for pain intensity. Although we discussed 
excluding the participants from the analysis, we chose to include them in the analysis since they 
had 4/10 at screening at the Outpatient Spine Clinic. We did, however, perform a sensitivity 
analysis without these two participants, and showed that pain intensity is still significantly 
reduced with VR training. 
Additionally, the original aim was to include highly kinesiophobic LBP patients (≥42/52). 
However, upon discussions with the recruiting clinic, it became evident that the Outpatient 
Spine Clinic have had very few participants who scored severe on TSK-11 (≥42/52) over the 
past years, an adjustment of the inclusion criterion was considered necessary. As suggested by 
the Outpatient Spine Clinic (and based on clinical experience), we altered the minimum score 
to ≥25 on TSK-11 (25/52) – thus including participants with mild, moderate and severe levels 
of kinesiophobia. Subsequently, five participants had a mild level of kinesiophobia, and four 




4.1.4. Considerations relevant to the procedure for data collection and outcome 
measures (and their assessment) 
The purpose of any experiment is to rule out plausible rival hypothesis or threats to internal 
validity (Cook & Campbell, 1979), such as history and maturation bias or statistical regression 
to the mean, familiarity with testing, and/or error with instrumentation. In an SSED, the use of 
standardized outcomes with known psychometric characteristics allows for determination of 
whether a person has made a reliable change and whether the change is significant (Jacobson 
et al, 1999). However, the SSED cannot rule out other threats to the validity (Morley et al, 
2015). The essence of a single-subject design is the repeated assessment over time of a target 
outcome and the manipulation of treatment condition (Morley et al, 2015). Specifically, an AB-
phase design requires a minimum of three measurement occasions per phase (Kratochwill et al, 
2010) which was successfully carried out across all participants. In addition, we selected 
specific outcomes that are functionally related to the treatment (Morley et al, 2015). In the 
present study, a representation of “highly salient items from standard questionnaires” (Morley 
et al, 2015) was chosen to track viable variables of fear and catastrophizing (similar to 
methodology used by Vlaeyen et al, 2012 and de Jong et al, 2012). A large database of patients 
with persistent musculoskeletal pain showed that the internal consistency of primary outcome 
measure subscales was sufficient to good (Chronbach a = 0.60, 0.72, and 0.73) for TSK, PCS 
and PASS, respectively (Roelofs et al, 2004). 
 
Participants were instructed to complete all daily measures (via self-report questionnaires) at 
the same time point each day: 8 p.m. every night. The approach has been shown sensitive to 
graded exposure therapy in previous studies (de Jong et al, 2005a; 2005b; 2008, Vlaeyen et al, 
2001; 2002a; 2002b), and although not tested for VR-interventions yet, the approach was 
evaluated as the most viable alternative to date. Consequently, participants were given 2-3 daily 
measure forms after each VR-training session, which they had to return to MS and TFL at the 
next appointment. Such regular check-in with the researchers ensured low levels of missing 
data. Further, participants adhered to the treatment schedule and appointments as planned. Only 
two participants had a prolonged baseline-period, of 1 and 2 days. As depicted in Table 9, all 
participants adhered to the 28-day schedule, while some participants had more than 7-days 
follow-up. ID22 and ID25 had a 2 and 1-day prolonged baseline, respectively. Five of the 
participants had an extended 7-day follow-up period (1-5 days) due to a number of reasons 
which we could not control, including work-related issues, illness, vacation and other reasons. 
All secondary outcome measures were collected successfully within a satisfactory time frame. 
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We are open to the possibility that collecting daily measures may be exhaustive as participants 
had to fill in 11 questions every day. This may be a particularly concern for pain intensity scores 
(NRS), which may prime the participant to focus on pain intensity every day, and thus may not 
be beneficial from a clinical perspective. Further, a current trend that may be discussed in future 
studies is whether we should rather focus on improvements in disability levels (i.e. scores 
related to ADL), because pain levels tends to come and go, occur in “flare-ups”, or sometimes 
be somewhat unpredictable for persistent LBP patients. However, the use of daily measures 
was considered ethically sound and necessary in the present study to adequately analyse how 
the participants responded to a new intervention. In the novel context of VR-training, it was 
also important to understand the daily fluctuations, as opposed to only seeing pre- and post-
measures, and long-term follow-up.  
Most participants filled in the forms without asking for help. However, we included one 
questionnaire in English (FreBAQ) in the secondary outcome measures, which led to need for 
translation and interpretation from some of the participants. We also included Recognise™, 
which seemed to work very well amongst the younger participants, but the older participants 
struggled with understanding the task at hand. This should be taken into consideration when 
looking at the results, and for future studies. Emphasis should be put on providing a careful 
explanation for all participants, ensuring that the task is well understood.  
Further, the two testing points for secondary measures were 5 weeks (35 days) apart, implying 
that there is a minimal risk of recall bias (i.e. that participants remembered which answer they 
gave at the different questionnaires). De Vet et al. (2015) suggests that the ability to recall a 
pain state accurately may be significantly reduced two weeks after the initial assessment.  It 
should be noted that most of the data collection was completed and all the interventions were 
provided by MS and TFL. Participants could therefore have experienced response bias when 
filling out questionnaires, due to the double role MS and TFL had in the study (i.e., not wanting 
to let the clinician know that a treatment was not helpful). However, none of the participants 
had any former relationship to the researcher MS or TFL, which does reduce the chance of this 
response bias. For future studies, a research assistant responsible for carrying out the 
intervention is preferable. 
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4.1.5. Considerations related to responsiveness of outcome measures 
When selecting assessment outcomes, researchers face the challenge of choosing between a 
myriad of objective and subjective assessments. Responsiveness of a measure to changes in 
status generally involve identification of a true change in the underlying construct of interest 
(Carter & Lubinsky, 2017). In the present study, NRS was selected over visual analogue scale 
(VAS) for pain intensity due to better psychometric properties. Specifically, previous studies 
have shown that NRS has been found to be a reliable scale in terms of inter- or intra-rater 
repeatability and its ability to detect change (Bijur et al, 2001; Boonstra et al, 2008; Hawker et 
al, 2011). Further, Ostelo et al. (2008) and Wright (1996) argues that a statistical significance 
does not necessarily mean that the change is clinically important. MIC values depend not only 
on empirical evidence but also on clinical interpretation and judgement (Ostelo et al, 2008). 
Therefore, we were also interested in the clinical relevance of the intervention, using MIC as 
an assessment outcome. A 30% improvement from baseline is considered a useful threshold for 
identifying clinically meaningful improvement for NRS (Ostelo et al, 2008). Although MIC is 
only validated for NRS and ODI in this context, we replicated the approach to investigate 
whether there was a MIC for TSK, PCS, PASS and the remaining secondary outcome measures. 
The authors of the study acknowledge the limitation with this approach, however; the study 
design is well suited for looking at clinical important changes across each participant. The final 
tenet related to responsiveness is that the TSK, PCS and PASS-items were collected as Likert 
scales (with 4, 5 and 6 questions, respectively), and subsequently transformed to percentage 
agreement (0-100) in order to be fitted into the linear mixed model analysis. One might argue 
that if we collected the items as numeric rating scales instead of Likert scales, it may have 
influenced the responsiveness of the questionnaires. However, converting the Likert scale to 0-
100 is not inconsistent with past research in this area. 
 
4.1.6 Considerations relevant to the statistical analysis 
In the present study, a sequential randomized and replicated single-subject experimental phase 
design with multiple measurements was analysed using a fitted linear mixed model (also 
referred to as a multilevel model) in lme4 with the R package in SPSS. The design and the 
analysis have the advantage of being valid for single-subject experiments, of being easy to 
apply, and for being versatile for even the most complex single-subject designs (Onghena & 
Edgington, 2005b). Although some researchers may prefer randomisation tests over linear 
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mixed effect analysis, the latter was considered the best approach when analysing the data set 
in the present study. The multilevel model regards the replicated case series data as “nested 
data”. So individual measurement occasions are nested in cases and the model takes into 
account that the measurement occasions are not independent of the person in which they are 
measured. The analysis computes a t-value based on the difference between baseline measures 
(programmed as 0 in the R-package and lme4) to intervention measures (programmed as 1) 
across all nine participants. The p-value is thereafter derived from a t-table (Appendix 5), 
depending on degrees of freedom. A randomisation test would perhaps address this limitation, 
as the analysis is more preferable as it makes less assumptions about the data. However, 
randomization tests are less flexible in terms of detecting an effect when the data show 
unexpected characteristics (i.e. high inter-subject variability, gradual treatment effects, trends, 
etc.), which makes linear mixed models better equipped to handle such complex data sets. In 
brief, that we used an analysis that takes into account interdependence of an individual’s scores 
as well as one that uses all available data (all daily scores regardless of differences in numbers 
between participant – e.g., different baseline and treatment durations), provides confidence in 
the study’s results. 
In our statistical analysis, we have depicted all daily measures in graphs showing daily changes 
in NRS, TSK, PCS and PASS. While we did not use the graphs to infer statistical effects of the 
intervention, they are useful tools to see daily fluctuations for each participant.  
 
4.1.7 Ethical considerations 
This study was approved by the regional ethics committee (2017/REK Vest/1199) 13.06.2017, 
and has been performed in a sound ethical and professional way. It has not been possible for 
MS or TFL to connect the ID-numbers received from the Outpatient Spine Clinic with 
participants’ names or other personal factors. Only JSS had the key to unlock this code at the 
Outpatient Spine Clinic, and all VR interventions were carried out at a different location. For 
future studies, a larger team with a research assistant blinded to treatment group (or, in this case, 
phase of the study) is preferable, but for this master’s project, this was not possible.  
All participants who were included in the study volunteered to participate after receiving written 
and oral information about the study. To ensure a thorough follow-up of all participants, the 
participants were offered a further follow-up in primary health care after the data collection was 
70 
completed (day 35), and MS was responsible for referring them back to the Outpatient Spine 
Clinic. Two participants (ID29 and ID30) decided to take this offer, because they still had a 
high pain levels and/or disability throughout the study, and accordingly when the present study 
was over, they were interested in accessing further primary health care services provided by the 
Outpatient Spine Clinic. Considering that the intervention was only five weeks long, and that 
participants had been screened by a whole team and evaluated as safe to start exercising prior 
to entering the VR study, and that participation was voluntary, the study was considered 
ethically sound. Finally, the study was considered an innovative and potentially important pilot 
study for the Outpatient Spine Clinic, who specialized on treatment on this patient group. 
 
4.2. Discussion and implications of the study results 
4.2.1. Primary outcome measure: Pain intensity (Numerical Rating Scale)  
This study found that pain intensity decreased by 1 point across all participants on an 11-point 
NRS during the VR intervention. Further, when considering the percentage change in scores 
between baseline and follow-up, improvements were maintained or increased in all participants. 
We were interested in whether the changes were reliable and statistically significant, and how 
the nine participants responded to the intervention. With the current design, we account for the 
number of days where the participants did not receive any intervention, versus the time period 
where they did. Hence, a reduction of -1.0 points represents the reduction across participants 
when accounting for a randomised baseline. In this way, we have strengthened the internal 
validity (i.e. maximized the design) of the study as much as possible.  
In the present study, four out of nine participants showed a MIC for pain. Of the remaining 
participants who did not have a MIC, two participants (ID27 and ID28) had decreasing pain 
intensity (NRS) levels during the baseline period, which may have caused a “floor effect” due 
to history, maturation or statistical regression to the mean. ID27 and ID28 were included in the 
primary data analysis, despite having low baseline scores because they did have 4/10 at 
screening at the Outpatient Spine Clinic. Indeed, when these participants were removed from 
the analysis (sensitivity analysis), pain intensity was still significantly reduced and pain 
intensity levels reduced by an average of 1.4 points. ID26 did have a pain intensity reduction, 
but not sufficient to be classified as a MIC.  
71 
On the opposite side of the scale, ID30 only showed high pain rating throughout the study, only 
a 1.07-point reduction in NRS, and little overall change in both primary and secondary outcome 
measures. Surprisingly, ID30 also experienced increased disability (+12% on ODI) at follow-
up (Day 35). One may speculate whether this patient had a more acute pain characteristic 
compared to other patients and that the VR training triggered unfavourable responses. Also, in 
contrast with the other 8 participants, ID30 was sick-listed for LBP for the first time, in contrast 
to others who had been sick listed 10 or more times for the same complaint. If we look to 
Kongsted et al.’s (2016) suggested principal trajectories, ID30 may be classified as having 
severe intensity (between 6-10 on NRS), persistent pain (as opposed to fluctuating, episodic or 
a single episode) with less than 1.0-point NRS variability over the course of 4 days, and no 
change pattern (as opposed to rapidly improving, gradually improving or progressive pain). 
Other participants show trajectories associated with fluctuating variability, or rapidly or 
gradually improving pain (Kongsted et al, 2016). Importantly, individual factors such as pain 
characteristics, time aspects and loading responses are therefore important components to 
consider when implementing VR as a tool in clinical practice. 
As shown Table 7 (See Subsection 3.2.2.2.), four participants had a MIC for pain intensity 
reduction. Interestingly, all four participants that achieved MIC for pain reduction were those 
randomised to a longer intervention phase, thus receiving the highest intervention dosage (8 or 
9 VR-training sessions) possible. Participants whose pain reduction did not exceed the MIC for 
pain were the ones randomised to a longer baseline duration (pre-treatment phase: 9-14 days) 
and thus, a lower dosage (6 or 7 VR-training sessions). The only exception to this was ID26 
who had 8 VR-training sessions (and a pre-treatment phase of 9 days), and pain reduction did 
not reach MIC (although it was close at -1.67). While not formally evaluated, such findings 
suggest that treatment dosage may be important. These findings may also explain why our study 
results showing a significant reduction in pain differed from that of Thomas et al. (2016) in 
which no significant effects on group change on expected pain or expected harm was observed. 
Thomas et al. (2016) had LBP participants perform only 3 VR-training sessions of 15 minutes 
each, and argue that their findings were not surprising given that graded exposure therapy for 
pain-related fear for persistent LBP patients usually consists of 8-12 treatments (as cited in 
Thomas et al (2016): Boersma et al, 2004; Leeuw et al, 2008; Linton et al, 2008; Woods & 
Amundson, 2008). While the Thomas’ study and our study also differed in the nature of the 
intervention protocol (i.e. they had a semi-immersive virtual environment (i.e. 3D-TV) while 
we used fully immersive VR-games in Oculus Rift), the intent of the VR games was similar in 
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both studies – to promote increased movement into trunk flexion and other trunk movements. 
Thus it is more likely that a higher dosage (6-9 VR-training sessions of 30 minutes in the present 
study vs 1-3 training sessions of 15 minutes in Thomas et al. 2016) may be behind the differing 
effects seen here. Therefore, this study adds value in the field by showing that a higher dosage 
of VR-training sessions with fully immersive VR-technology demonstrated a statistically 
significant effect on pain intensity (NRS), pain-related fear of movement (TSK), pain 
catastrophizing (PCS) and pain anxiety symptoms (PASS). However, more research is needed 
to investigate how to optimize graded exposure training in VR for persistent LBP patients. 
 
4.2.2. Primary outcome measures: Pain-related fear of movement (TSK), pain 
catastrophizing (PCS) and pain anxiety symptoms (PASS) 
The present study also suggests that pain-related fear of movement (TSK), pain catastrophizing 
(PCS) and pain anxiety symptoms (PASS) are statistically significant reduced with VR training. 
The analysis of changes in TSK, PCS and PASS show that the reduction is small, and most 
participants do not have scores that are a 30% reduction from baseline scores. Only ID25 
showed a clinically meaningful reduction for TSK, and only ID22 showed a meaningful 
reduction for PCS and PASS. Additionally, the graphs for TSK, PCS and PASS show high 
intra-case variability across participants (Figure 22).  
With regards to the aforementioned outcome measures, two pressing questions are: 1) Do the 
questionnaires used in the present study reflect the construct we are trying to assess changes in 
(i.e. what is the construct validity and responsiveness?), and 2) If pain and fear are complex 
intertwined emergent properties, would objective measurements (i.e. self-reported 
questionnaires) be the best way to describe a subjective embodied experience? To discuss the 
first question, we may look to Lundberg et al. (2011), who wrote that questionnaires 
investigating pain-related fear of movement, kinesiophobia, fear-avoidance beliefs and so forth 
were all developed earlier than the emergence of the Fear-Avoidance Model by Vlaeyen in 
1995. One may therefore wonder what the underlying conceptual framework for all these 
questionnaires are, and the authors of the critical review argue that in most cases, the conceptual 
framework is missing. Lundberg et al. (2011) concluded that the weak construct validity implies 
that no measure can currently identify who is fearful, and that the lack of evidence for 
responsiveness restricts current use of the instruments to identify clinically relevant change 
from treatment (Lundberg et al, 2011). These are important suggestions to take into account 
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when investigating pain-related fear of movement in LBP participants. To date, only one study 
(which is not yet peer-reviewed) has looked at the neural correlates that underlie the different 
constructs (Meier et al, 2018), and more research in this field is likely to follow.  
To discuss the second question, we might touch upon the relevance of implicit evaluations of 
danger and safety (Moseley & Butler, 2016). Contemporary pain science theories propose that 
pain and fear are dependent on implicit evaluations of danger to the body, and that thoughts or 
beliefs such as “lifting something heavy may cause more damage to my lower back” or “the 
severe pain I’m experiencing must indicate that something is terribly wrong with my back” may 
sometimes represent implicit (unconscious) and not explicit evaluations (information that need 
conscious reflection, that you are aware of, and willing to disclose) (Fazio et al, 2003; 
Greenwald et al, 1998; Leeuw et al, 2007; Van Ryckeghem et al, 2013). Another question is 
whether these implicit evaluations may drive behaviour in an adaptive (e.g. health-promoting) 
or maladaptive (e.g. fear-avoidant) direction. This raises two points; whether there is a presence 
of self-protect bias, meaning that participants may be hesitant to reveal sensitive information 
about themselves, and whether the best way to evaluate pain-related fear of movement is via of 
self-report questionnaires. Thus, more research is needed to investigate whether existing self-
report questionnaires are adequate for clinical and research purposes when looking into pain-
related fear of movement. One recent study by Caneiro (2017), investigated physiological 
responses (i.e. eye-blink reflex, startle response and skin conductance) in relation to images 
perceived as “dangerous” (i.e. lifting with round back) to LBP patients, but no connections were 
found. It may be argued that pain-related fear of movement is a very context-dependent state-
type of fear, which is indeed hard to conceptualize, and equally, challenging to detect with the 
measurement tools currently available. 
 
4.2.3. Secondary outcome measures 
In the present study, four secondary outcome measures were collected at Day 1 and Day 35 for 
all participants. More specifically, we found that 4 out of 9 participants met the MIC for the 
ODI, which is interesting considering that the interventions only ranged between 6 and 9 
treatments applied over 14-23 days. ODI is an important clinical measure, because changes in 
disability may be a more stable measure than daily fluctuations in pain. Disability levels 
represents changes in function in ADL, such as getting dressed, sitting or standing, but it also 
has to do with social aspects of life such as being able to function at work (sitting or standing), 
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or travelling. However, whether tailored VR-training may aid in reducing disability through the 
development of cost-effective therapeutic tools will have to be investigated with full scientific 
rigour in future studies, controlling for history and maturation bias, as well as statistical 
regression to the mean. 
The ÖMPSQ short form was included in the present study because the questionnaire addresses 
some important “yellow flag” risk factors in LBP patients, namely related to pain or harm 
expectancies as a result of movement. Our study showed a reduction in ÖMPSQ short form 
score for 7 out of 9 participants. Two participants went from above the cut-off score (i.e. 
≥50/100) for risk of future disability, to beneath. In total, 1 patient had a ≥30% reduction in 
ÖMSPQ short form from baseline to follow-up. Although the questionnaire is only validated as 
a screening tool, we wanted to include it because it addresses some points for LBP patients that 
are consistent with what we wanted to investigate for future studies (i.e.  Item 9: “An increase 
in pain is an indication that I should stop what I’m doing until the pain decreases”, and Item 10: 
“I should not do my normal work (at work or home duties) with my present pain”). Interestingly, 
some of these aspects changed in our participants during the course of the study (i.e. ID26 went 
from scoring 10 to 8 on item 9, and 10 to 7 on item 10 from baseline to follow-up). Future 
studies may provide researchers and clinicians with more information about whether VR-
training sessions can be used to educate the patients differentiation between “pain and harm 
expectancies” (Weermeijer & Meulders, 2018), i.e. that the expectancy of pain may increase in 
the course of introducing a new exercise regimen, but that the expectancy of harm should 
decrease concurrently with implementation of graded exposure therapy targeting correction of 
erroneous interpretations of an impeding catastrophe (Meulders et al, 2017). However, the 
authors of the present study acknowledge that other questionnaires may inherent improved 
psychometric properties to assess “yellow flag” risk factors and pain or harm expectancies than 
the ÖMPSQ short form. Nevertheless, the ÖMPSQ short form provided us with information 
about pre- and post-assessments that may be valuable for future studies in the field. 
The FreBAQ scores showed high inter-case variability, and no particular trends towards a 
change in a positive or negative direction. Four out of nine participants had a reduction in 
FreBAQ scores equivalent to a MIC (30% reduction from baseline), but some participants also 
had increase in FreBAQ score, or no change from baseline to follow-up. The high inter-case 
variability may have been influenced by language barriers, because the questionnaire only 
exists in English to date. The results should therefore be interpreted with caution. However, 
similar to ÖMSPQ short form, FreBAQ also represent interesting aspects related to persistent 
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pain that we would like to investigate in future studies with VR-training. More specific, we 
were interested in the response to items such as item 1 and 6: “My back feels like it is not part 
of the rest of my body” and “I can’t perceive the exact outlines of my back” and whether the 
present LBP sample showed any responsiveness to questions related to body perception. There 
is a growing body of evidence about the altered body perception in persistent pain (Kregel et 
al, 2015; Wand et al, 2014), which might contribute to the pain experience as well as serve as 
a target for treatment (Louw et al, 2015, Wand et al, 2016). Therefore, future research is 
warranted to investigate whether the use of VR may be specifically programmed to challenge 
and re-train perceptual dysfunctions, and whether these changes are related to reductions in pain 
scores and disability. 
Implicit motor imagery assessment (via Recognise ™; Noigroup) was conducted to explore 
body perception – specifically working body schema (the cortical maps that underlie movement 
planning, coordination, and execution). Our results showed that all participants became 
significantly faster at judging images of right-side trunk rotation/lateral flexion after VR-based 
treatments. It is unclear why the improvement was specific to right side images, but the results 
may indicate familiarity with the test-method, random fluctuations, or greater ability to mentally 
manoeuvre their own body part to fit the pictured image (Parsons, 2001). Moreover, accurate 
left/right judgements depend on intact working body schemas (Parsons, 2001). Only two 
participants showed improvements with left-sided judgements. The present study showed 
improved accuracy scores with left sided judgements for five out of nine participants, while two 
participants had improvements in right sided accuracy judgements. However, accuracy scores 
show a high inter- and intra-case variability, so the results should be interpreted with caution.  
Although we did not specifically tailor the VR-intervention towards improving motor imagery 
performance in the present study, it was still interesting to investigate LBP participants’ 
responses to the Recognise ™ app, and whether the scores changed between the two 
measurement points in relation to the VR-intervention. What we found in the present study was 
that the participants had speed responses that were overall faster at follow-up (Table 8). More 
specifically, speed responses were faster than expected for LBP patients (1.8 seconds +/- 0.5 
seconds) (compared to Bowering et al (2014) study), but both speed and accuracy seemed to 
have a high inter- and intra-case variance. Interestingly, we saw that younger participants scored 
higher on accuracy throughout the study, which may be due to user acceptance. Only ID25 and 
ID28 showed improvements in both speed and accuracy from baseline to follow-up. 
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Emerging advances in neuroscience and brain imaging studies have shown that decreased 
movement in the lumbar spine leads to functional changes in the brain (Flor et al, 1997; Wand 
et al, 2011a), which is related to a dynamically maintained neuronal representation of body 
parts (Flor et al, 1997, 1998; Lotze & Moseley 2007, Maihofner et al, 2003, Moseley et al, 
2005a, Moseley et al, 2008b). Whether these cortical changes play a causal role in non-specific 
LBP has not been established (Apkarian et al, 2009). However, treatments such as graded motor 
imagery (GMI) targeting the restoration of cortical function have been shown effective in 
phantom limb pain (Flor et al, 2001; Moseley, 2006) and complex regional pain syndrome 
(CRPS) (McCabe et al, 2003; Moseley, 2004; 2006; 2008a). In line with these findings, a SSED 
study (n=3) on graded sensorimotor retraining demonstrated effectiveness on pain intensity for 
persistent LBP patients (Wand et al, 2011b), and a case-study (n=16) by Louw et al. (2015) 
demonstrated immediate effects on pain intensity and MIC for forward flexion using sensory 
discrimination training in persistent LBP patients. Thus, it may appear that changes related to 
tactile acuity (Luomajoki & Moseley, 2010; Moseley, 2008b; Wand et al, 2010), altered body 
perception (Moseley, 2008) and disrupted body schema (Bray & Moseley, 2010) could be 
viable therapeutic targets for persistent LBP management. However, in a recent systematic 
review, Bowering et al. (2013) suggested that although GMI and mirror therapy alone may be 
effective, further rigorous studies is needed to evaluate the effectiveness of GMI for a wider 
population of persistent pain conditions. Future studies may also explore the utilization of VR 
technology in order to develop novel therapeutic interventions in this field.   
 
4.2.4. Results related to patient satisfaction 
In the present study, we were primarily interested in quantitative results as presented earlier, 
but because the study design and protocol had never been tested before, we also included a 
qualitative evaluation questionnaire for each participant at the end of each trial with five open 
questions related to participants’ experiences with the VR-training (i.e. “How did you 
experience the VR-training?”, or “In your opinion, how could a VR-intervention be tailored the 
individual patient during LBP rehabilitation?”). In summary, all participants expressed that they 
felt motivated, engaged, and would like to continue using VR-training in the future. Further, 
they expressed that the intervention was fun and entertaining, and some participants also 
expressed that they were less fearful in ADL during and after, the VR-training. One participant 
wrote in the evaluation form that “Continuity in the training is very important to me. Being 
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supervised and experiencing progress in the different VR-games was very motivating”, and 
another participant wrote: “During this study, I got to train muscle groups that I do not use on 
a daily basis, which I think is very good for my lower back in the long run”. Some participants 
expressed that they would be interested in playing VR-games that was more tailored to their 
own interests, and more related to their challenges in ADL. This is important feedback for future 
studies to address in order to achieve meaningful and clinically relevant changes, considering 
that is was not the primary emphasis of the present study. Importantly, the participants did not 
report any side effects from the VR-training and no patients dropped out of the study. A full 
overview over patient feedback is provided in Appendix 11. 
 
4.2.5. Strengths and limitations with the study 
4.2.5.1. Strengths 
All patients were screened by the Outpatient Spine Clinic and evaluated as safe to start 
exercising. This was very beneficial for us as researchers, considering that all red flags, serious 
neurological injuries and/or neuropathic LBP pain was ruled out by a team of experts at the 
Outpatient Spine Clinic. Participants where thus ready to start exercising with VR-training 
based on safe premises. We also recruited a consecutive sample of patients attending the clinic, 
which may represent the type of LBP patient typically seen in this particular primary health 
care setting. Another strength is the concept of the study, i.e. to target underlying psychological 
and/or behavioural factors in treatment of persistent LBP. The intervention combined 
encouragement of graded exposure towards lumbar spine flexion and trunk rotation while 
providing distraction from pain-related fear and confrontation of feared movement (i.e. lumbar 
spine flexion). Additionally, the VR-training was used to explore movements in a safe virtual 
environment, with a tailored, person-centred approach (n = 1). The tailored approach consisting 
of: “easy”, “medium” or “hard” levels was adjusted similar to exercise programs in the clinic, 
based on scores on daily questionnaires of pain intensity (NRS), pain-related fear of movement 
(TSK), pain catastrophizing (PCS), pain-anxiety symptoms (PASS), in addition to feedback 
from the patient and clinical observations. Furthermore, the daily measures allowed us to track 
the individual changes in each participant over time. The study design, the randomisation of 
baseline and intervention duration strengthened the internal validity and provided a robust and 
maximized SSED. There were no drop-outs in the study, and adherence between planned and 
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actual execution of treatment schedule was satisfactory carried out, which was important for 
the validity of the statistical analysis. 
Another strength is that the games used in the protocol were flexible and easy to adjust in real-
time. We got permission to use two commercial games from the software developers of 
Holoball and Holodance, and TFL developed the third VR-game “RoBow Agent”. The protocol 
for the VR-training was developed by a team of experienced physiotherapists and researchers 
(TS, KVF, MS), in collaboration with the master student in software engineering (TFL). 
Participants of all ages were able to use the equipment and understood how to navigate in the 
VR-platform, which makes the intervention available and scalable for use in rehabilitation 
centres, in the clinic or home settings. The trans-disciplinary collaboration in the present study 
was beneficial for the development of a viable intervention for LBP, as we could learn from 
each other to create a new therapeutic treatment tool. In the larger perspective, the collaboration 
between health care professionals and computer engineering may provide cost-effective 
treatment options in the future. Persistent musculoskeletal pain has been under-prioritized and 
under-funded for decades, mainly because it is categorized as a non-fatal disease (Hoy et al, 
2010). More specifically, a report showed that persistent musculoskeletal research received 
only 6% of national funding budget in Norway in 2003 (Lærum et al, 2013), while at the same 
time, accounting for 46% of sick leave and 33% of disability pension. New technological 
advancements and innovative therapies may be necessary to create a sustainable primary health 
care system in response to the global burden of persistent LBP. Importantly, LBP management 
must be driven by the administration of treatments with the highest probability for success (i.e. 
high-value treatments versus low-value treatments) (Foster et al, 2018). The development of 
novel therapeutic interventions also needs to consider this.  
 
4.2.5.2. Limitations 
The present study had some limitations. First and foremost, the study design involves a low 
number of participants needed (due to the increased power conferred by within subject 
analyses) and does not provide us with a control group. Specifically, the lack of control group 
makes it more difficult to control for history and maturation bias or statistical regression to the 
mean (Carter & Lubinsky, 2017). More research is therefore needed to investigate whether the 
results shown in the study are replicable and generalizable to larger samples. However, in a 
replicated case series design we do have adequate participant numbers needed to perform robust 
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statistical analysis as suggested by several lines of research (e.g. Onghena et al, 1995; 2005a; 
2005b; Michiels & Onghena, 2018). 
Other methodological aspects that could have been improved include: daily measures of 
fear/catastrophising/pain-anxiety could have been converted to NRS continuums instead of 
using the original Likert scales during the data collection (i.e. replicate de Jong (2012)). This 
may have improved responsiveness of pain-related fear of movement (TSK), pain 
catastrophizing (PCS) and pain-anxiety symptoms (PASS). However, converting the original 
Likert scale to 0-100 scales is not inconsistent with past research in this area. Further, the use 
of the English questionnaire (FreBAQ) may have showed improved responsiveness if it was 
translated for a Norwegian population. However, we did not do any analysis using the 
questionnaire, we merely calculated change scores between to assessment points. 
Administering PSFS at Day 35 should have been better implemented to prevent omission. 
Employment of a research assistant blinded to the interventions, that could carry out the 
outcome measurement collection could potentially reduce response bias (i.e., not wanting to let 
the clinician know that a treatment was not helpful) amongst the participants. Additionally, it 
would have been interesting to not only have a 7-day follow-up, but also have a longer follow-
up (e.g., 3-months) to see how the participants did some time after the intervention. 
Unfortunately, we did not have time or resources for that in this master’s project.  
The protocol for the VR-training had not been tested on healthy participants, with the exception 
of the researchers, prior to the present study with LBP patients. The researchers MS and TFL 
were responsible for finding and adjusting two commercial games (Holoball and Holodance) 
with permission from the developers, and TFL developed the third game (RoboBow). Through 
significant clinical testing and software programming, we managed to create a protocol that we 
thought would fit our participants. The intervention could have been improved by administering 
pilot testing with LBP patients before we initiated the present study, but we were limited by 
time constraints of the master’s program. Importantly, two of the games were already 
commercially available, they would have been tested by healthy people, and the third game was 
tailored specifically for this target population (i.e. LBP-patients with fear of movement). 
However, this pilot study may serve that purpose for other, larger studies, and we were satisfied 
with the VR-games that we chose as they were considered safe, fun, engaging and easily 
adjustable in real-time (while participants played the game). Further, as seen in Table 7 (See 
Subsection 3.2.2.2.), some participants received only 6 VR-interventions, while others were 
randomized to receive 7, 8 or 9 training. It would have been interesting to investigate whether 
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the results would have been different if all participants received the same dosage (i.e., ≥8) or 
whether it is possible to develop a flexible protocol that accentuates a MIC for pain and 
disability with a minimal amount of interventions per patient (i.e. provides high costs-
effectiveness). 
Some researchers argue that pain is likely to fluctuate in persistent LBP patients, and that 
disability changes is a much more interesting variable to investigate. Others argue that having 
an intense focus on pain as a measure may “prime” the patient towards a negative focus. That 
our results showed a reduction in pain following VR-based treatment suggest that daily pain 
measures did not prime patients towards a negative focus. Further, any changes in pain 
medication were not assessed. Instead, we asked participants to qualitatively describe and report 
whether their pain medication intake had changed throughout the study. This was therefore not 
included as an outcome measure in the present study but will remain important for future 
studies. Finally, the notion of non-specific LBP may include a variety of pain characteristics, 
which may have become evident in primary and secondary outcome measures for ID30. 
Namely, ID30 may have had a more severe and persistent pain characteristic (according to 
characteristics described by Kongsted et al, 2016), experienced constant pain, and severe 
exacerbations with minimal activity (i.e. 5 minutes of standing). Therefore, a screening 
procedure that differentiated between different pain characteristics may be helpful for future 
studies to determine which patients could benefit the most from VR-based interventions for 
LBP. In summary, all these limitations are acknowledged by the authors of the present study 
and must be addressed in future studies to improve methodological and scientific rigour. 
 
4.2.6. Comparison to previous studies in this area  
There is a current lack of evidence for the effectiveness of VR training for non-specific 
persistent LBP, so it would be relevant to discuss existing literature VR in health care to create 
perspective. Finally, suggestions for future directions are presented in the next subsection. 
While VR gaming shows considerable success in the area of acute pain, few studies have 
applied VR to persistent pain management. To date, only one systematic review related to the 
use of VR in inpatient medical settings has been published. Dascal et al. (2017) reviewed 11 
randomised, controlled trials and found that VR is a promising intervention for pain distraction 
(Carrougher et al, 2009; Hoffman et al, 2008; Kipping et al, 2012; Morris et al, 2010; Patterson 
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et al, 2010; Schmitt et al, 2011), eating disorders/obesity (Cesa et al, 2013, Manzoni et al, 2009), 
and cognitive and motor rehabilitation (Larson et al, 2011). However, no systematic review for 
the use of VR in physical rehabilitation of persistent pain has been published to date. A number 
of recent studies have demonstrated that virtual feedback interventions can provide pain relief 
for a variety of persistent pain conditions (e.g., for hand osteoarthritis (Gilpin et al, 2015; 
Preston & Newport, 2011); hand dystonia (Llobera et al, 2013); upper extremity neuropathic 
pain (Mouraux et al, 2016); knee osteoarthritis (Stanton et al, 2018)). More specifically related 
to persistent LBP and pain-related fear of movement, Parsons & Trost (2014) have developed 
VRGET (Virtual Reality Graded Exposure Therapy), defined as a therapeutic approach that aim 
to address several major limitations characterizing traditional graded exposure therapy. This 
includes “mitigating costs associated with traditional graded exposure therapy, enhance 
participant engagement, provide real-time assessment of important metrics such as affective 
response and kinematic adaptation, and provide generalizability of rehabilitation gains across 
clinic and home environments” (Parsons & Trost, 2014, p: 523). A protocol for a pilot study 
was published in 2015, but no studies have been published to date. 
Therefore, Thomas et al. (2016) published the first feasibility study (n=52) on VR-dodgeball 
for kinesiophobic LBP patients, and a phase 2 clinical trial for Virtual Rehabilitation to 
Optimize Recovery (VIGOR) is expected to follow based on a protocol published in 2018. 
Importantly, as mentioned previously, Thomas et al. provided patients with 3 VR-interventions 
of 15 minutes each, and the study did not demonstrate any statistically significant effect on 
expected pain or expected harm across participants. In contrast, the present study with 6 to 9 
VR-intervention of 30 minutes per intervention, 2-3x per week, over 14-23 days, did 
demonstrate a statistically significant reduction in pain intensity (NRS), pain-related fear of 
movement (TKS), pain catastrophizing (PCS) and pain-anxiety symptoms (PASS). 
Additionally, the present study showed that participants who had 8 or 9 VR-sessions had a 
larger reduction in pain intensity scores (NRS) compared to participants who only received 6 
or 7 VR-sessions. Further research seems necessary to explore the importance of dosage of VR-
trainings to achieve treatment effects related to pain and disability in persistent LBP patients. 
 
4.2.7. Perspective and future directions 
Considering the rising epidemic of persistent musculoskeletal pain, it is important to investigate 
innovative solutions that may improve persistent LBP management. Researchers and clinicians 
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have come a long way implementing the biopsychosocial, cognitive, functional, behavioural, 
person-centred approach, but there is still a way to go in order to assimilate contemporary pain- 
and neuroscience theories and LBP research into clinical practice and public knowledge. 
Leading researchers in the field rightfully suggests a cultural shift (i.e. paradigm shift) is needed 
to translate updated knowledge to the general population through mass media campaigns 
(Foster et al, 2018; Hartvigsen et al, 2018; O’Sullivan et al, 2018b). The authors’ impression is 
that a cultural shift will take time and sustainable efforts over many decades. On the contrary, 
VR and AR are emerging forefront technological platforms which may benefit health care 
providers and patients alike. VR and AR may be useful to motivate and engage in physical 
activity during rehabilitation, and for educating patients about how thoughts and feelings (e.g. 
catastrophic thinking or pain-related fear of movement) are connected to movement strategies, 
and even so, how it may drive pain-related fear or avoidance behaviour. The possibility and 
opportunity to create “optimal learning environments” with VR is an exciting new field for 
physical therapists and patients. However, the effectiveness of VR-interventions is likely to 
depend on immersiveness, content, quality and relevance of the tasks and the virtual 
environments provided. Further, more research is needed with regards to dosage in relation to 
individual characteristics. Subsequently, investigating whether VR may be effective merely due 
to its entertainment value, or whether there are unique qualities that we can capitalize on in the 
clinical setting, seems necessary. Considering that VR-training is a novel therapeutic 
intervention, it is equally important to investigate possible side-effects, limitations, barriers and 
challenges with implementing new technology in physical rehabilitation. In summary, VR-
training as proposed to date may seem like a promising treatment persistent LBP patients, but 








VR training is an exciting tool for non-specific persistent LBP patients in primary health care. 
In the present study, we have shown that there was a statistically significant reduction in pain 
intensity (NRS), pain-related fear of movement (TSK), pain catastrophizing (PCS) and pain-
anxiety symptoms (PASS). The authors of the study acknowledge the threats to internal validity 
provided by the design of the study and suggests that larger studies with robust designs and a 
control group investigate VR for non-specific persistent LBP further in the future. However, to 
our knowledge, this study is the first study in Norway to investigate VR-training for persistent 
LBP-patients. This can be an important pilot study for future work in the field that combines 
physical therapy rehabilitation and the use of immersive virtual tools. Virtual tools may aid in 
creating a more sustainable health care system by providing patients with viable alternatives to 
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Appendix 3 – Assessment during VR-training 
Målinger underveis i VR-treningen 
Smerte 
Hvordan vil du gradere de smertene du opplever? 
0    1        2        3        4        5         6          7          8         9          10 




Hvordan vil du gradere de frykten du opplever? 
0    1        2        3        4        5         6          7          8         9          10 




Hvordan vil du gradere ubehaget du opplever? 
0    1        2        3        4        5         6          7          8         9          10 




Hvordan vil du gradere kvalmen du opplever? 
0    1        2        3        4        5         6          7           8         9          10 
Ingen kvalme                                                                                 Så kvalm som det går an å bli 
 
113 
Appendix 4 – Primary and secondary measures 
Daglige målinger 
Numerisk smerteskala                                                                            Dato: ……………….. 
Hvordan vil du gradere de smertene du har hatt i løpet av den siste uken. Sett ring rundt ett tall. 
 
 
0            1             2            3            4            5             6            7           8            9              10 
 
 
Ingen smerter                                                                                           Så vondt som det går an å ha 
 
 
Tampa Scale for Kinesiophobia (TSK) - Norwegian Version 
  Svært uenig Uenig Enig Svært enig 
1 Jeg er redd for at jeg kan skade meg ved et 
uhell 
    
2 Kroppen min forteller meg at noe er alvorlig 
galt 
    
3 Jeg kan ikke gjøre alle de tingene folk fleste 
gjør, fordi jeg har så lett for å bli skadet. 
    
 
Pain Catastrophizing Scale (PCS) - Norwegian version 
  










1 Det er forferdelig og jeg tror at det aldri vil 
bli bedre 
     
2 Jeg føler at jeg ikke klarer å fortsette      
3 Jeg lurer på om noe alvorlig kan komme til 
å skje 
     
 
Pain Anxiety Symptoms Scale (PASS-20 Short form) – English version 












1 When I hurt I think about pain constantly       
2 I find it hard to concentrate when I hurt       
3 I worry when I am in pain       




Secondary outcome measures 
Oswestry Disability Index  
Section 1 – Pain Intensity   
  I have no pain at the moment.  
  The pain is very mild at the moment.  
  The pain is moderate at the moment.  
  The pain is fairly severe at the moment.  
  The pain is very severe at the moment.  
  The pain is the worst imaginable at the moment.  
  
Section 2 – Personal Care (washing, dressing, etc.)  
  I can look after myself normally but it is very painful.  
  I can look after myself normally but it is very painful.  
  It is painful to look after myself and I am slow and careful.  
  I need some help but manage most of my personal care.  
  I need help every day in most aspects of my personal care.  
  I need help every day in most aspects of self-care.  
  I do not get dressed, wash with difficulty, and stay in bed.  
  
Section 3 - Lifting  
  I can lift heavy weights without extra pain.  
  I can lift heavy weights but it gives extra pain.  
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  Pain prevents me from lifting heavy weights off  the floor, but I can manage if they are 
conveniently positioned (i.e. on a table).  
  Pain prevents me from lifting heavy weights, but I can manage light to medium weights if 
they are conveniently positioned.  
  I can lift only very light weights.  
  I cannot lift or carry anything at all.  
  
Section 4 – Walking  
  Pain does not prevent me walking any distance.  
  Pain prevents me walking more than 1mile.  
  Pain prevents me walking more than ¼ of a mile.  
  Pain prevents me walking more than 100 yards.  
  I can only walk using a stick or crutches.  
  I am in bed most of the time and have to crawl to the toilet.  
  
Section 5 – Sitting  
    I can sit in any chair as long as I like.  
    I can sit in my favorite chair as long as I like.  
    Pain prevents me from sitting for more than 1 hour.  
    Pain prevents me from sitting for more than ½ hour.  
    Pain prevents me from sitting for more than 10     minutes.  
    Pain prevents me from sitting at all.  
  
Section 6 – Standing  
  I can stand as long as I want without extra pain.  
  I can stand as long as I want but it gives me extra pain.  
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  Pain prevents me from standing more than 1 hour.  
  Pain prevents me from standing for more than ½ an hour.  
  Pain prevents me from standing for more than 10 minutes.  
  Pain prevents me from standing at all.  
  
Section 7 – Sleeping  
  My sleep is never disturbed by pain.  
  My sleep is occasionally disturbed by pain.  
  Because of pain, I have less than 6 hours sleep.  
  Because of pain, I have less than 4 hours sleep.  
  Because of pain, I have less than 2 hours sleep.  
  Pain prevents me from sleeping at all.  
  
Section 8 – Sex life (if applicable)  
  My sex life is normal and causes no extra pain.  
  My sex life is normal but causes some extra pain.  
  My sex life is nearly normal but is very painful.  
  My sex life is severely restricted by pain.  
  My sex life is nearly absent because of pain.  
  Pain prevents any sex life at all.  
  
Section 9 – Social Life  
  My social life is normal and cause me no extra pain.  
  My social life is normal but increases the degree of pain.  
  Pain has no significant effect on my social life apart from limitingmy more energetic 
interests, i.e. sports.  
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  Pain has restricted my social life and I do not go out as often.  
  Pain has restricted social life to my home.  
  I have no social life because of pain.  
  
Section 10 – Traveling  
  I can travel anywhere without pain.  
  I can travel anywhere but it gives extra pain.  
  Pain is bad but I manage journeys of over two hours.  
  Pain restricts me to short necessary journeys under 30 minutes.  






   
  
Fremantle Back Awareness Questionnaire (FreBAQ) 
Item 
Never  Rarely  Occasionally  Often Always  
1. My back feels as though it is not part of 
the rest of my body 
     
2. I need to focus all my attention on my 
back to make it move the way I want it 
to 
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3. I feel as if my back sometimes moves 
involuntarily, without my control 
     
4. When performing everyday tasks, I 
don’t know how my back is moving 
     
5. When performing everyday tasks, I am 
not always sure where my back is in 
space 
     
6. I can’t perceive the exact outline of my 
back 
     
7. My back feels like it is enlarged 
(swollen) 
     
8. My back feels like it has shrunk      
9. My back feels lopsided (asymmetrical)      
 
Protocol for the Recognise ™ 
1. Patients will be informed that they will look at pictures and then quickly decide 
whether the person in the picture is rotating towards the left or right. 
2. The person is told to use left index finger to press “left” and the right index finger to 
press “right”. 
3. The participant will be introduced to the app via “Vanilla”, which is an easy 
introduction level with 20 images, max time of 5 seconds. 
4. Then the participant is tested using: “test”. 
5. The participant will be going through 2 x 40 images. 





The Patient-Specific Functional Scale  
This useful questionnaire can be used to quantify activity limitation and measure functional 
outcome for patients with any orthopaedic condition.  
Clinician to read and fill in below: Complete at the end of the history and prior to physical 
examination.  
Initial Assessment:  
I am going to ask you to identify up to three important activities that you are unable to do or 
are having difficulty with as a result of your _________________ problem.  Today, are there 
any activities that you are unable to do or having difficulty with because of your 
_________________ problem? (Clinician: show scale to patient and have the patient rate each 
activity).  
Follow-up Assessments:  
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When I assessed you on (state previous assessment date), you told me that you had difficulty 
with (read all activities from list at a time).  Today, do you still have difficulty with: (read and 
have patient score each item in the list)?  
Patient-specific activity scoring scheme (Point to one number):  
0  1  2  3  4  5  6  7  8  9  10  
Unable to  
perform   
activity   
Able to perform 
activity at the 
same level as 
before injury or 
problem  
  
(Date and Score)  
  
Activity  Initial            
1.              
2.              
3.              
4.              
5.              
Additional              
Additional              
  
Total score = sum of the activity scores/number of activities  
PSFS developed by:  Stratford, P., Gill, C., Westaway, M., & Binkley, J. (1995). Assessing disability and change 




















ID21 was removed from the data analysis due to a very low NRS-score at baseline, which 
should have been detected earlier. The participant registered 4/10 on NRS scale during 
screening at the Outpatient Spine Clinic 26.04.18, but when meeting with MS and TFL 11.05.18 
for enrolment in the study, pain levels had continued to drop to 1/10. The participant should 
therefore have been excluded before entering the study and will be excluded from the data 
analysis. Additionally, two participants (ID26 and ID27) showed abnormal low NRS scores and 
we chose to do a sensitivity analysis on these two participants. Results are shown in subsection 
























ÖMPSQ short form FreBAQ 
 Baseline FU Change,% Baseline FU Change Baseline FU Change  
ID22 56% 42% -14% 74 64 -13,51% 17,8% 4,4% -13,4% 
ID23 48% 52% +4% 57* 46* -19,29% 35,5%  24,4% -11,1% 
ID24 38% 24% -14% 46 34 -26,08% 15,5% 20% +4,5% 
ID25 54% 36% -18% 35 28 -20% 53,3% 11,1% -42,2% 
ID26 70% 52% -18% 66 71 +7,57% 8,88% 11,1% +2,23% 
ID27 36% 32% -4% 24 16 -33,33% 22,2% 12,2% -20% 
ID28 30% 28% -2% 21 26 +23,80% 0 0 0 
ID29 62% 64% +2% 58* 48* -17,24% 17,8% 15,6% -2,2% 
ID30 44% 56% +12% 56 52 -7,14% 0 4,4% +4,4% 
Table 1: secondary outcome measures for ODI, ÖMPSQ short form and FreBAQ. Notes: Reductions in scores 
are marked in “bold” headings. 
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 Left Right Left Right 
 Baseline FU Change 
% 
Baseline FU Change 
% 
Baseline FU Change Baseline FU Change 
ID22 0,95 1,8 +47,2% 2,95 1,2 -59,3% 25% 55% +30% 85% 65% -20% 
ID23 1,2 3 +60% 2,0 1,7 -15% 80% 80% 0 75% 60% -15% 
ID24 0,8 1 +20% 1,3 1,15 -11,5% 75% 80% +5% 90% 90% 0 
ID25 2,5 1,65 -34% 1,55 1,4 -9,7% 35% 65% +30% 30% 55% +25% 
ID26 0,8 0,9 +11,1% 1,2 0,85 -29,1% 90% 95% +5% 90% 85% -5% 
ID27 1,05 0,85 -19% 1,1 0,8 -27,3% 95% 90% -5% 100% 75% -25% 
ID28 0,9 0,8 -11,1% 1,2 1 -16,7% 90% 95% +5% 95% 100% +5% 
ID29 1,35 1,05 -22,2% 1,9 0,85 -55,3% 100% 85% -15% 95% 70% -25% 
ID30 0,8 0,6 -25% 1 0,75 -25% 85% 85% 0 95% 85% -10% 
Table 1: Recognise ™ change scores. Notes: Improvements in Recognise™ scores are marked in “bold” headings. 
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Appendix 9 - Patient Specific Functional Scale (PSFS)  
Due to an administrative error at follow-up, we decided to exclude the questionnaire from the analysis. 
Participants were given two different form: one at baseline and one a follow-up, which resulted in 
participants registering difficulties with different tasks from testing point 1 to testing point 2 (e.g. 
making it harder to measure change in the same task). This resulted in many missing values at follow-
up. Explanation of scores: score: 0 = unable to perform activity, 10 = able to perform activity at the same 
level as before injury or problem. The questionnaire was excluded from the analysis. 
 
ID Q# Question  Baseline Follow-up Change 
ID22 Q1 Lifting heavy 4 5 1 
  Q2 Carrying heavy things 3 5 2 
  Q3 Vacuuming 4 4 0 
ID23 Q1 Sitting in excavator 3 5 2 
  Q2 Sitting in a truck 3 5 2 
  Q3 Sitting in the office 3 missing 0 
ID24 Q1 Driving far 4 missing   
  Q2 Certain tasks at work 4 5 1 
  Q3 Strength training 2 missing missing 
ID25 Q1 Sitting 2 missing missing 
  Q2 Walking uphill 2 missing missing 
  Q3 Shower 2 missing missing 
ID26 Q1 Walking 4 5 1 
  Q2 Sitting  4 5 1 
  Q3 Bending forwards 2 8 6 
ID7 Q1 Working 4 7 3 
  Q2 Walking/hiking 6 9 3 
  Q3 Lifting   6 8 2 
ID28 Q1 missing missing missing missing 
  Q2 missing missing missing missing 
  Q3 missing missing missing missing 
ID29 Q1 Doing the dishes 0 0 0 
  Q2 Dressing 4 5 1 
  Q3 Bowling 8 8 0 
ID30 Q1 Sitting 2 2 0 
  Q2 Lifting 3 3 0 
  Q3 missing missing missing Missing 
Table 1: only ID26 and ID27 show MIC for some tasks. However, there are too many missing 






























Participant TSK score 
ID22 25/52 (mild) 
ID23 37/52 (moderate) 
ID24 35/52 (moderate) 
ID25 28/52 (mild) 
ID26 32/52 (mild) 
ID27 34/52 (moderate) 
ID28 25/52 (mild) 
ID29 25/52 (mild) 
ID30 38/52 (moderate) 
Table 1: TSK-11 score at baseline 
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Appendix 11 – Patient evaluation of the VR-study 
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